这是一篇来自已证抗体库的有关人类 HLA-DR (HLA-DR) 的综述,是根据366篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合HLA-DR 抗体。
HLA-DR 同义词: HLA-DRA1

BioLegend
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s1b
BioLegendHLA-DR抗体(Biolegend, 307606)被用于被用于流式细胞仪在人类样本上 (图 s1b). Stem Cell Res Ther (2022) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上. J Exp Med (2022) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 e9a
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 e9a). Nature (2022) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 1:100; 图 6b, s26
BioLegendHLA-DR抗体(Biolegend, 307609)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 6b, s26). Nat Nanotechnol (2022) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 1:300; 图 6b
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上浓度为1:300 (图 6b). Nat Commun (2021) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 3b
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 3b). Acta Neuropathol (2021) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上. Immunity (2021) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 小鼠
BioLegendHLA-DR抗体(Biolegend, 307632)被用于被用于流式细胞仪在小鼠样本上. J Autoimmun (2021) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 图 4d
BioLegendHLA-DR抗体(Biolegend, 327007)被用于被用于流式细胞仪在人类样本上 (图 4d). Oncogene (2021) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 3a
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 3a). elife (2020) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s3c
BioLegendHLA-DR抗体(BioLegend, 307610)被用于被用于流式细胞仪在人类样本上 (图 s3c). Cell (2021) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1b
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 1b). J Immunother Cancer (2020) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 2e
BioLegendHLA-DR抗体(BioLegend, 307638)被用于被用于流式细胞仪在人类样本上 (图 2e). Cell (2020) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s1c
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 s1c). BMC Cancer (2020) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 3:50; 图 1c
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上浓度为3:50 (图 1c). Science (2020) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类; 图 s1b
BioLegendHLA-DR抗体(Biolegend, 361607)被用于被用于流式细胞仪在人类样本上 (图 s1b). J Clin Invest (2020) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 1:100; 图 s20c
BioLegendHLA-DR抗体(Biolegend, 307642)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 s20c). Nat Commun (2020) ncbi
小鼠 单克隆(L243)
  • mass cytometry; 人类; 500 ug/ml; 图 s11a
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于mass cytometry在人类样本上浓度为500 ug/ml (图 s11a). Nature (2020) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s20
BioLegendHLA-DR抗体(Biolegend, 307640)被用于被用于流式细胞仪在人类样本上 (图 s20). Science (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 6b
BioLegendHLA-DR抗体(Biolegend, 307640)被用于被用于流式细胞仪在人类样本上 (图 6b). Cell Rep (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 7a
BioLegendHLA-DR抗体(BioLegend, 307629)被用于被用于流式细胞仪在人类样本上 (图 7a). J Exp Med (2020) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s6c
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 s6c). Science (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 1:50; 图 e4f
BioLegendHLA-DR抗体(Biolegend, 307619)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 e4f). Nature (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上. JCI Insight (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 2d
BioLegendHLA-DR抗体(Biolegend, 307642)被用于被用于流式细胞仪在人类样本上 (图 2d). Immunity (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s2d
BioLegendHLA-DR抗体(Biolegend, 307602)被用于被用于流式细胞仪在人类样本上 (图 s2d). Cell (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 8a
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 8a). elife (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1b
BioLegendHLA-DR抗体(Biolegend, 307626)被用于被用于流式细胞仪在人类样本上 (图 1b). Cell Mol Gastroenterol Hepatol (2020) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 6
BioLegendHLA-DR抗体(BioLegend, 307603)被用于被用于流式细胞仪在人类样本上 (图 6). Gastroenterol Res Pract (2019) ncbi
小鼠 单克隆(Tu39)
  • 抑制或激活实验; 人类; 20 ug/ml; 图 s3i
BioLegendHLA-DR抗体(Biolegend, 361702)被用于被用于抑制或激活实验在人类样本上浓度为20 ug/ml (图 s3i). Cancer Cell (2019) ncbi
小鼠 单克隆(L243)
  • 其他; 人类; 图 4b
BioLegendHLA-DR抗体(BioLegend, 307659)被用于被用于其他在人类样本上 (图 4b). Cell (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s1
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 s1). JCI Insight (2019) ncbi
小鼠 单克隆(L243)
  • mass cytometry; 人类; 图 s1
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于mass cytometry在人类样本上 (图 s1). J Exp Med (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s1b
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 s1b). J Clin Invest (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1a
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 1a). BMC Res Notes (2019) ncbi
小鼠 单克隆(L243)
  • mass cytometry; 人类; 图 2b
BioLegendHLA-DR抗体(Biolegend, 307602)被用于被用于mass cytometry在人类样本上 (图 2b). Cell (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 1:100; 图 s1c, s3a
BioLegendHLA-DR抗体(Biolegend, 307650)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 s1c, s3a). Cancer Cell (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 2 ug/ml; 图 s13
BioLegendHLA-DR抗体(BioLegend, 307623)被用于被用于流式细胞仪在人类样本上浓度为2 ug/ml (图 s13). Science (2019) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 图 3g
BioLegendHLA-DR抗体(Biolegend, 327014)被用于被用于流式细胞仪在人类样本上 (图 3g). Science (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 3a
BioLegendHLA-DR抗体(BioLegend, 307624)被用于被用于流式细胞仪在人类样本上 (图 3a). J Clin Invest (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 1:1; 图 5a
BioLegendHLA-DR抗体(BioLegend, 307610)被用于被用于流式细胞仪在人类样本上浓度为1:1 (图 5a). Nat Commun (2019) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 图 1a
BioLegendHLA-DR抗体(Biolegend, LN3)被用于被用于流式细胞仪在人类样本上 (图 1a). Front Immunol (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1a
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 1a). Front Immunol (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 1:200; 图 1b
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 1b). Front Immunol (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s3k
BioLegendHLA-DR抗体(Biolegend, 307618)被用于被用于流式细胞仪在人类样本上 (图 s3k). Cell Rep (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 小鼠; 图 3b
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于流式细胞仪在小鼠样本上 (图 3b). J Clin Invest (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 4a
BioLegendHLA-DR抗体(BioLegend, 307618)被用于被用于流式细胞仪在人类样本上 (图 4a). J Exp Med (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s1c
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 s1c). J Immunol (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1a
BioLegendHLA-DR抗体(Biolegend, 307602)被用于被用于流式细胞仪在人类样本上 (图 1a). Cell (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s2d
BioLegendHLA-DR抗体(BioLegend, 307624)被用于被用于流式细胞仪在人类样本上 (图 s2d). Nat Immunol (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1a
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 1a). J Immunol (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s3b
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 s3b). J Exp Med (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1a
BioLegendHLA-DR抗体(Biolegend, 307616)被用于被用于流式细胞仪在人类样本上 (图 1a). J Clin Invest (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1a
BioLegendHLA-DR抗体(Biolegend, 307616)被用于被用于流式细胞仪在人类样本上 (图 1a). Nucleic Acids Res (2018) ncbi
小鼠 单克隆(L243)
  • 抑制或激活实验; 人类; 图 s2b
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于抑制或激活实验在人类样本上 (图 s2b). Nat Med (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s1
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 s1). J Biol Chem (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 4a
BioLegendHLA-DR抗体(BioLegend, H243)被用于被用于流式细胞仪在人类样本上 (图 4a). Int J Infect Dis (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1b
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 1b). JCI Insight (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 3b
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 3b). Oncol Lett (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1a
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 1a). J Exp Med (2018) ncbi
小鼠 单克隆(L243)
  • mass cytometry; 人类; 图 2a
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于mass cytometry在人类样本上 (图 2a). Proc Natl Acad Sci U S A (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 1:50
BioLegendHLA-DR抗体(BioLegend, 307616)被用于被用于流式细胞仪在人类样本上浓度为1:50. Science (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 表 s3
BioLegendHLA-DR抗体(biolegend, L243)被用于被用于流式细胞仪在人类样本上 (表 s3). Cell (2017) ncbi
小鼠 单克隆(L243)
  • mass cytometry; 人类; 图 1h
  • 流式细胞仪; 人类
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于mass cytometry在人类样本上 (图 1h) 和 被用于流式细胞仪在人类样本上. Science (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s6a
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 s6a). MBio (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 st12
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 st12). Science (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 2e
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 2e). Oncoimmunology (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 1:200; 图 s1d
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 s1d). Nat Commun (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 2b
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 2b). Genome Med (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 小鼠; 图 2d
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于流式细胞仪在小鼠样本上 (图 2d). J Clin Invest (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 猕猴; 图 7a
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在猕猴样本上 (图 7a). J Virol (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 表 1
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (表 1). Cytometry A (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 3b
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 3b). Oncotarget (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上. J Exp Med (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 2a
BioLegendHLA-DR抗体(BioLegend, 307606)被用于被用于流式细胞仪在人类样本上 (图 2a). Oncogene (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 小鼠; 图 1c
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于流式细胞仪在小鼠样本上 (图 1c). J Immunol (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 表 2
BioLegendHLA-DR抗体(Biolegend, 307624)被用于被用于流式细胞仪在人类样本上 (表 2). J Allergy Clin Immunol (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 2b
BioLegendHLA-DR抗体(Biolegend, 307628)被用于被用于流式细胞仪在人类样本上 (图 2b). Cell Death Dis (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上. J Allergy Clin Immunol (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1b
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 1b). Eur J Immunol (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 6a
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 6a). J Biol Chem (2016) ncbi
小鼠 单克隆(LN3)
  • 免疫细胞化学; 人类; 0.5 ug/ml; 图 1
BioLegendHLA-DR抗体(Biolegend, 327002)被用于被用于免疫细胞化学在人类样本上浓度为0.5 ug/ml (图 1). Microbes Infect (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 2b
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 2b). PLoS ONE (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 7a
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 7a). J Biol Chem (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s3
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 s3). Nature (2016) ncbi
小鼠 单克隆(Tu39)
  • 流式细胞仪; 人类; 表 1
BioLegendHLA-DR抗体(BioLegend, Tu39)被用于被用于流式细胞仪在人类样本上 (表 1). J Immunol (2016) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 表 1
BioLegendHLA-DR抗体(BioLegend, LN3)被用于被用于流式细胞仪在人类样本上 (表 1). J Immunol (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 3
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 3). Am J Transplant (2016) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 1:400; 图 2
BioLegendHLA-DR抗体(Biolegend, LN3)被用于被用于流式细胞仪在人类样本上浓度为1:400 (图 2). PLoS ONE (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s1c
  • 免疫细胞化学; 人类
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 s1c) 和 被用于免疫细胞化学在人类样本上. J Allergy Clin Immunol (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 1:200; 图 s1a
BioLegendHLA-DR抗体(Biolegend, 307616)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 s1a). Acta Neuropathol (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s6a
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 s6a). Oncotarget (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 1:20; 图 2
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上浓度为1:20 (图 2). Nat Commun (2016) ncbi
小鼠 单克隆(L243)
  • 其他; 人类; 图 st1
  • 流式细胞仪; 人类; 图 st3
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于其他在人类样本上 (图 st1) 和 被用于流式细胞仪在人类样本上 (图 st3). Mol Cell Proteomics (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1a
BioLegendHLA-DR抗体(BioLegend, 307610)被用于被用于流式细胞仪在人类样本上 (图 1a). J Immunol (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s1b
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 s1b). J Immunol (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1
BioLegendHLA-DR抗体(Biolegend, 307628)被用于被用于流式细胞仪在人类样本上 (图 1). PLoS ONE (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上. Clin Cancer Res (2016) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 图 1
BioLegendHLA-DR抗体(Biolegend, clone LN3)被用于被用于流式细胞仪在人类样本上 (图 1). PLoS ONE (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
BioLegendHLA-DR抗体(Biolegend, 307604)被用于被用于流式细胞仪在人类样本上. Cytometry A (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 2a
BioLegendHLA-DR抗体(Biolegend, 307602)被用于被用于流式细胞仪在人类样本上 (图 2a). Mol Med Rep (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 表 1
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (表 1). Cytometry B Clin Cytom (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 3
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 3). Mucosal Immunol (2016) ncbi
小鼠 单克隆(Tu39)
  • 流式细胞仪; 人类
BioLegendHLA-DR抗体(Biolegend, #361703)被用于被用于流式细胞仪在人类样本上. Am J Transplant (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 表 s1
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (表 s1). PLoS ONE (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 9a
BioLegendHLA-DR抗体(Biolegend, 307617)被用于被用于流式细胞仪在人类样本上 (图 9a). EMBO Mol Med (2015) ncbi
小鼠 单克隆(L243)
  • 抑制或激活实验; 人类; 15 ug/ml; 图 4
BioLegendHLA-DR抗体(BioLegend, L432)被用于被用于抑制或激活实验在人类样本上浓度为15 ug/ml (图 4). Vaccine (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
BioLegendHLA-DR抗体(BioLegend, clone L243)被用于被用于流式细胞仪在人类样本上. Chest (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 5
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 5). Clin Cancer Res (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 3
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上 (图 3). Nephrol Dial Transplant (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上. Eur J Immunol (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于流式细胞仪在人类样本上. J Leukoc Biol (2014) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1
BioLegendHLA-DR抗体(Biolegend, 307604)被用于被用于流式细胞仪在人类样本上 (图 1). PLoS Pathog (2014) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上. Blood (2014) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上. Front Immunol (2014) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 6b
BioLegendHLA-DR抗体(Biolegend, L243)被用于被用于流式细胞仪在人类样本上 (图 6b). J Immunol (2014) ncbi
小鼠 单克隆(L243)
BioLegendHLA-DR抗体(Biolegend, L243)被用于. J Immunol (2014) ncbi
小鼠 单克隆(L243)
  • 抑制或激活实验; 人类; 图 5A
BioLegendHLA-DR抗体(BioLegend, L243)被用于被用于抑制或激活实验在人类样本上 (图 5A). J Immunol (2014) ncbi
赛默飞世尔
小鼠 单克隆(LN3)
  • 免疫组化; 小鼠; 1:200; 图 s3
赛默飞世尔HLA-DR抗体(Invitrogen, 14-9956-82)被用于被用于免疫组化在小鼠样本上浓度为1:200 (图 s3). Mol Neurodegener (2021) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 图 1b
赛默飞世尔HLA-DR抗体(Invitrogen, 47-9956-41)被用于被用于流式细胞仪在人类样本上 (图 1b). Stem Cell Res Ther (2021) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 1:100; 图 s3e
赛默飞世尔HLA-DR抗体(eBioscience, 25-9956-42)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 s3e). Immunity (2021) ncbi
小鼠 单克隆(LN3)
  • 免疫组化; 小鼠; 1:750
赛默飞世尔HLA-DR抗体(eBioscience, 14-9956-82)被用于被用于免疫组化在小鼠样本上浓度为1:750. Acta Neuropathol Commun (2021) ncbi
小鼠 单克隆(LN3)
赛默飞世尔HLA-DR抗体(ThermoFisher, 14-9956-82)被用于. Antioxidants (Basel) (2021) ncbi
小鼠 单克隆(LN3)
  • 免疫组化-石蜡切片; 人类; 1:1000; 图 2-a3
赛默飞世尔HLA-DR抗体(eBioscience, 14-9956)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:1000 (图 2-a3). Cells (2020) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类; 图 3b
赛默飞世尔HLA-DR抗体(Thermofisher, Q22158)被用于被用于流式细胞仪在人类样本上 (图 3b). elife (2020) ncbi
小鼠 单克隆(TU36)
  • mass cytometry; 人类; 图 2b, 2s8a
赛默飞世尔HLA-DR抗体(Invitrogen, Tu36)被用于被用于mass cytometry在人类样本上 (图 2b, 2s8a). elife (2020) ncbi
小鼠 单克隆(LN3)
  • 免疫组化; 小鼠; 图 1
赛默飞世尔HLA-DR抗体(eBioscience, LN3)被用于被用于免疫组化在小鼠样本上 (图 1). JCI Insight (2019) ncbi
小鼠 单克隆(LN-3)
  • 免疫组化; 小鼠; 图 1
赛默飞世尔HLA-DR抗体(eBioscience, LN3)被用于被用于免疫组化在小鼠样本上 (图 1). JCI Insight (2019) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 图 6c
赛默飞世尔HLA-DR抗体(Ebioscience, 47-9956-42)被用于被用于流式细胞仪在人类样本上 (图 6c). Oncoimmunology (2019) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 图 3c
赛默飞世尔HLA-DR抗体(eBioscience, 12-9956-42)被用于被用于流式细胞仪在人类样本上 (图 3c). Cell Rep (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 3c
赛默飞世尔HLA-DR抗体(eBioscience, 11-9952-41)被用于被用于流式细胞仪在人类样本上 (图 3c). Cell (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 3a
赛默飞世尔HLA-DR抗体(eBioscience, L243)被用于被用于流式细胞仪在人类样本上 (图 3a). J Clin Invest (2019) ncbi
小鼠 单克隆(LN3)
  • 免疫组化; 人类; 1:1000; 图 2f
赛默飞世尔HLA-DR抗体(eBioscience, 14-99-56-82)被用于被用于免疫组化在人类样本上浓度为1:1000 (图 2f). Clin Exp Immunol (2018) ncbi
小鼠 单克隆(LN-3)
  • 流式细胞仪; 人类; 图 st12
赛默飞世尔HLA-DR抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上 (图 st12). Science (2017) ncbi
小鼠 单克隆(MEM-267)
  • 免疫印迹; 人类; 图 3d
赛默飞世尔HLA-DR抗体(Thermo Fischer Scientific, MA1-19393)被用于被用于免疫印迹在人类样本上 (图 3d). Toxicol In Vitro (2017) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 图 5a
赛默飞世尔HLA-DR抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上 (图 5a). Stem Cells (2017) ncbi
小鼠 单克隆(LN-3)
  • 流式细胞仪; 人类; 图 5a
赛默飞世尔HLA-DR抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上 (图 5a). Stem Cells (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 猕猴; 图 1a
赛默飞世尔HLA-DR抗体(Fisher Scientific, L243)被用于被用于流式细胞仪在猕猴样本上 (图 1a). J Immunol (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔HLA-DR抗体(eBioscience, L240)被用于被用于流式细胞仪在人类样本上 (图 1a). J Clin Invest (2017) ncbi
小鼠 单克隆(LN-3)
  • 流式细胞仪; 人类; 图 4a
赛默飞世尔HLA-DR抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上 (图 4a). PLoS ONE (2016) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔HLA-DR抗体(Invitrogen, MHLDR31)被用于被用于流式细胞仪在人类样本上 (图 1a). Rev Soc Bras Med Trop (2016) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类; 图 s2
赛默飞世尔HLA-DR抗体(ThermoFisher Scientific, Q22158)被用于被用于流式细胞仪在人类样本上 (图 s2). Cytometry B Clin Cytom (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DR抗体(eBioscience, L243)被用于被用于流式细胞仪在人类样本上. Int J Cancer (2017) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔HLA-DR抗体(eBioscience, 11-9956)被用于被用于流式细胞仪在人类样本上 (图 1). Stem Cell Reports (2016) ncbi
大鼠 单克隆(YD1/63.4.10)
  • 流式细胞仪; 人类; 图 4b
赛默飞世尔HLA-DR抗体(Thermo Fisher, MA1-70113)被用于被用于流式细胞仪在人类样本上 (图 4b). Nanomedicine (Lond) (2016) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔HLA-DR抗体(Invitrogen, T-36)被用于被用于流式细胞仪在人类样本上 (图 1a). AIDS Res Hum Retroviruses (2016) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔HLA-DR抗体(eBioscience, 45-9956-41)被用于被用于流式细胞仪在人类样本上 (图 2). Stem Cell Reports (2016) ncbi
小鼠 单克隆(LN-3)
  • 流式细胞仪; 人类; 图 2f
赛默飞世尔HLA-DR抗体(Invitrogen, LN3)被用于被用于流式细胞仪在人类样本上 (图 2f). PLoS Pathog (2016) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 图 2f
赛默飞世尔HLA-DR抗体(Invitrogen, LN3)被用于被用于流式细胞仪在人类样本上 (图 2f). PLoS Pathog (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 1:50; 图 s2c
赛默飞世尔HLA-DR抗体(ebioscience, L243)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 s2c). Nat Med (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 1:20; 图 s5j
赛默飞世尔HLA-DR抗体(eBioscience, 12-9952-41)被用于被用于流式细胞仪在人类样本上浓度为1:20 (图 s5j). Nat Cell Biol (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 st1
赛默飞世尔HLA-DR抗体(eBiosciences, L243-ef450)被用于被用于流式细胞仪在人类样本上 (图 st1). J Allergy Clin Immunol (2016) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类; 表 2
赛默飞世尔HLA-DR抗体(Invitrogen, VXMHLDR17)被用于被用于流式细胞仪在人类样本上 (表 2). Sci Rep (2016) ncbi
小鼠 单克隆(LN-3)
  • 流式细胞仪; African green monkey
赛默飞世尔HLA-DR抗体(eBioscience, LN3)被用于被用于流式细胞仪在African green monkey样本上. Infect Immun (2016) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; African green monkey
赛默飞世尔HLA-DR抗体(eBioscience, LN3)被用于被用于流式细胞仪在African green monkey样本上. Infect Immun (2016) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔HLA-DR抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上 (图 1). Immunol Res (2016) ncbi
小鼠 单克隆(LN-3)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔HLA-DR抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上 (图 1). Immunol Res (2016) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 1:200; 图 st3
赛默飞世尔HLA-DR抗体(eBioscience, 12-9956-42)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 st3). Leukemia (2016) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 猕猴; 图 5
赛默飞世尔HLA-DR抗体(生活技术, MHLDR17)被用于被用于流式细胞仪在猕猴样本上 (图 5). PLoS ONE (2015) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 图 3
赛默飞世尔HLA-DR抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上 (图 3). Mucosal Immunol (2016) ncbi
小鼠 单克隆(LN-3)
  • 流式细胞仪; 人类; 5:100; 图 s3
赛默飞世尔HLA-DR抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上浓度为5:100 (图 s3). Nat Commun (2015) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 5:100; 图 s3
赛默飞世尔HLA-DR抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上浓度为5:100 (图 s3). Nat Commun (2015) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DR抗体(BD, MHLDR01)被用于被用于流式细胞仪在人类样本上. Cancer Res (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DR抗体(eBioscience, 25-9952-41)被用于被用于流式细胞仪在人类样本上. Nanomedicine (2015) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DR抗体(生活技术, MHLDR01)被用于被用于流式细胞仪在人类样本上. Biochem Pharmacol (2015) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DR抗体(eBioscience, 11-9956)被用于被用于流式细胞仪在人类样本上. J Pediatr Surg (2014) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DR抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上. J Allergy Clin Immunol (2015) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DR抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上. Hum Immunol (2015) ncbi
小鼠 单克隆(LN3)
  • 免疫细胞化学; 人类
赛默飞世尔HLA-DR抗体(eBioscience, LN3)被用于被用于免疫细胞化学在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(LN-3)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 2
赛默飞世尔HLA-DR抗体(Thermo, MA1-35420)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 2). Hum Mol Genet (2014) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DR抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上. J Exp Med (2014) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DR抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DR抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上. J Infect Dis (2014) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DR抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上. Leukemia (2014) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DR抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上. PLoS Pathog (2014) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类; 1:20; 图 s6
赛默飞世尔HLA-DR抗体(Invitrogen, Tu36)被用于被用于流式细胞仪在人类样本上浓度为1:20 (图 s6). Nat Med (2013) ncbi
小鼠 单克隆(LN-3)
  • 流式细胞仪; 人类; 图 3b
赛默飞世尔HLA-DR抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上 (图 3b). J Infect Dis (2014) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类; 图 3b
赛默飞世尔HLA-DR抗体(eBioscience, LN3)被用于被用于流式细胞仪在人类样本上 (图 3b). J Infect Dis (2014) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DR抗体(eBioscience, L243)被用于被用于流式细胞仪在人类样本上. J Hepatol (2014) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DR抗体(Caltag Laboratories, clone Tu36)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2013) ncbi
小鼠 单克隆(LN-3)
  • 免疫组化-石蜡切片; 猕猴; 1:50; 图 2
赛默飞世尔HLA-DR抗体(生活技术, LN3)被用于被用于免疫组化-石蜡切片在猕猴样本上浓度为1:50 (图 2). PLoS ONE (2013) ncbi
小鼠 单克隆(LN3)
  • 免疫组化-石蜡切片; 猕猴; 1:50; 图 2
赛默飞世尔HLA-DR抗体(生活技术, LN3)被用于被用于免疫组化-石蜡切片在猕猴样本上浓度为1:50 (图 2). PLoS ONE (2013) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 猕猴; 图 2a
赛默飞世尔HLA-DR抗体(Invitrogen, TU36)被用于被用于流式细胞仪在猕猴样本上 (图 2a). Hum Vaccin Immunother (2012) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DR抗体(Caltag Laboratories, MHLDR05)被用于被用于流式细胞仪在人类样本上. J Leukoc Biol (2012) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 S2
赛默飞世尔HLA-DR抗体(eBioscience, 48-9952-42)被用于被用于流式细胞仪在人类样本上 (图 S2). Proc Natl Acad Sci U S A (2012) ncbi
小鼠 单克隆(LN3)
  • 免疫组化-石蜡切片; 猕猴; 1:200; 表 2
  • 流式细胞仪; 猕猴; 图 7
赛默飞世尔HLA-DR抗体(Zymed Laboratory, clone LN-3)被用于被用于免疫组化-石蜡切片在猕猴样本上浓度为1:200 (表 2) 和 被用于流式细胞仪在猕猴样本上 (图 7). J Pathol (2008) ncbi
小鼠 单克隆(LN-3)
  • 免疫组化-石蜡切片; 猕猴; 1:200; 表 2
  • 流式细胞仪; 猕猴; 图 7
赛默飞世尔HLA-DR抗体(Zymed Laboratory, clone LN-3)被用于被用于免疫组化-石蜡切片在猕猴样本上浓度为1:200 (表 2) 和 被用于流式细胞仪在猕猴样本上 (图 7). J Pathol (2008) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类; 1:50
赛默飞世尔HLA-DR抗体(Caltag, MHLDR04)被用于被用于流式细胞仪在人类样本上浓度为1:50. Methods Mol Biol (2007) ncbi
小鼠 单克隆(TU36)
  • 免疫组化; 人类; 图 2
赛默飞世尔HLA-DR抗体(Caltag, MHLDR01)被用于被用于免疫组化在人类样本上 (图 2). Immunology (2004) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DR抗体(Caltag, TU36)被用于被用于流式细胞仪在人类样本上. Pediatr Res (2004) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DR抗体(Caltag, TU36)被用于被用于流式细胞仪在人类样本上. Cytometry B Clin Cytom (2003) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔HLA-DR抗体(Caltag, TU36)被用于被用于流式细胞仪在人类样本上 (图 4). J Virol (2003) ncbi
小鼠 单克隆(LN-3)
  • 免疫组化-冰冻切片; 人类; 图 6
  • 流式细胞仪; 人类; 图 4
赛默飞世尔HLA-DR抗体(Zymed, LN-3)被用于被用于免疫组化-冰冻切片在人类样本上 (图 6) 和 被用于流式细胞仪在人类样本上 (图 4). Int Immunol (2002) ncbi
小鼠 单克隆(LN3)
  • 免疫组化-冰冻切片; 人类; 图 6
  • 流式细胞仪; 人类; 图 4
赛默飞世尔HLA-DR抗体(Zymed, LN-3)被用于被用于免疫组化-冰冻切片在人类样本上 (图 6) 和 被用于流式细胞仪在人类样本上 (图 4). Int Immunol (2002) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DR抗体(Caltag, TU 36)被用于被用于流式细胞仪在人类样本上. Infect Immun (2000) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DR抗体(Caltag, TU36)被用于被用于流式细胞仪在人类样本上. Br J Haematol (1999) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类
赛默飞世尔HLA-DR抗体(Caltag, TU36)被用于被用于流式细胞仪在人类样本上. Proc Natl Acad Sci U S A (1999) ncbi
艾博抗(上海)贸易有限公司
domestic rabbit 单克隆(EPR3692)
  • 免疫组化; 人类; 1:50; 图 4e
艾博抗(上海)贸易有限公司HLA-DR抗体(Abcam, ab92511)被用于被用于免疫组化在人类样本上浓度为1:50 (图 4e). Front Immunol (2021) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 3a
艾博抗(上海)贸易有限公司HLA-DR抗体(Abcam, ab136320)被用于被用于流式细胞仪在人类样本上 (图 3a). PLoS Pathog (2021) ncbi
domestic rabbit 单克隆(EPR3692)
  • 免疫组化-石蜡切片; 人类; 1:200; 图 6m
艾博抗(上海)贸易有限公司HLA-DR抗体(Abcam, 92511)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 6m). PLoS Genet (2021) ncbi
domestic rabbit 单克隆
  • 免疫组化-石蜡切片; 猕猴; 1:500; 图 s8b
艾博抗(上海)贸易有限公司HLA-DR抗体(Abcam, ab215312)被用于被用于免疫组化-石蜡切片在猕猴样本上浓度为1:500 (图 s8b). Science (2020) ncbi
domestic rabbit 单克隆(EPR3692)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 8a
艾博抗(上海)贸易有限公司HLA-DR抗体(Abcam, ab92511)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 8a). J Exp Med (2020) ncbi
domestic rabbit 单克隆(EPR3692)
  • 免疫细胞化学; 人类; 图 2G
艾博抗(上海)贸易有限公司HLA-DR抗体(Abcam, ab92511)被用于被用于免疫细胞化学在人类样本上 (图 2G). Reproduction (2016) ncbi
小鼠 单克隆(LN3)
  • 流式细胞仪; 人类
艾博抗(上海)贸易有限公司HLA-DR抗体(Abcam, ab95830)被用于被用于流式细胞仪在人类样本上. J Biol Chem (2013) ncbi
圣克鲁斯生物技术
小鼠 单克隆(TAL 1B5)
  • 免疫印迹; 人类; 图 3a
圣克鲁斯生物技术HLA-DR抗体(Santa Cruz Biotechnology, sc-53319)被用于被用于免疫印迹在人类样本上 (图 3a). Oncoimmunology (2018) ncbi
小鼠 单克隆(DA6.147)
  • 免疫印迹; 人类; 图 2a
圣克鲁斯生物技术HLA-DR抗体(SantaCruz, DA6.147)被用于被用于免疫印迹在人类样本上 (图 2a). Childs Nerv Syst (2017) ncbi
小鼠 单克隆(ML11C11)
  • 免疫组化-石蜡切片; 人类; 1:50; 图 1
圣克鲁斯生物技术HLA-DR抗体(santa Cruz, sc-73366)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50 (图 1). PLoS ONE (2016) ncbi
小鼠 单克隆(TAL 1B5)
  • 免疫组化; 人类; 1:1000; 图 3
  • 免疫印迹; 人类; 1:5000; 图 2
圣克鲁斯生物技术HLA-DR抗体(Santa Cruz Biotechnology, sc-53319)被用于被用于免疫组化在人类样本上浓度为1:1000 (图 3) 和 被用于免疫印迹在人类样本上浓度为1:5000 (图 2). Nat Commun (2016) ncbi
小鼠 单克隆(CR3/43)
  • 免疫组化; 人类; 1:1000; 图 s5
圣克鲁斯生物技术HLA-DR抗体(Santa Cruz Biotechnology, sc-53302)被用于被用于免疫组化在人类样本上浓度为1:1000 (图 s5). Nat Commun (2016) ncbi
大鼠 单克隆(ER-TR3)
  • 免疫组化; 小鼠; 图 5
圣克鲁斯生物技术HLA-DR抗体(Santa Cruz, sc-59318)被用于被用于免疫组化在小鼠样本上 (图 5). PLoS ONE (2015) ncbi
小鼠 单克隆(TAL 1B5)
  • 免疫组化-石蜡切片; 猫
圣克鲁斯生物技术HLA-DR抗体(Santa Cruz Biotechnology, TAL 1B5)被用于被用于免疫组化-石蜡切片在猫样本上. Vet Immunol Immunopathol (2015) ncbi
小鼠 单克隆(520B)
  • 免疫印迹; 人类
圣克鲁斯生物技术HLA-DR抗体(Santa Cruz, sc-69673)被用于被用于免疫印迹在人类样本上. J Biomed Mater Res A (2015) ncbi
小鼠 单克隆(TAL 1B5)
  • 免疫印迹; 人类
圣克鲁斯生物技术HLA-DR抗体(Santa Cruz, sc-53319)被用于被用于免疫印迹在人类样本上. Clin Ther (2014) ncbi
美天旎
人类 单克隆(REA805)
  • mass cytometry; 人类; 图 s7f
美天旎HLA-DR抗体(Miltenyi Biotec, 130-122-299)被用于被用于mass cytometry在人类样本上 (图 s7f). Cell Rep (2022) ncbi
小鼠 单克隆(AC122)
  • 流式细胞仪; 人类; 图 4c
美天旎HLA-DR抗体(Miltenyi Biotec, AC122)被用于被用于流式细胞仪在人类样本上 (图 4c). Cell Death Dis (2019) ncbi
伯乐(Bio-Rad)公司
小鼠 单克隆(HL-39)
  • 流式细胞仪; 人类; 图 4f
伯乐(Bio-Rad)公司HLA-DR抗体(serotec, MCA1879)被用于被用于流式细胞仪在人类样本上 (图 4f). Exp Gerontol (2014) ncbi
贝克曼库尔特实验系统(苏州)有限公司
小鼠 单克隆(Immu-357)
  • 流式细胞仪; 人类; 1:10
贝克曼库尔特实验系统(苏州)有限公司HLA-DR抗体(Beckman Coulter, immu-357)被用于被用于流式细胞仪在人类样本上浓度为1:10. elife (2020) ncbi
小鼠 单克隆(Immu-357)
  • 流式细胞仪; 人类; 图 1b
贝克曼库尔特实验系统(苏州)有限公司HLA-DR抗体(Beckman, PN IM3635)被用于被用于流式细胞仪在人类样本上 (图 1b). BMC Infect Dis (2019) ncbi
小鼠 单克隆(Immu-357)
  • 流式细胞仪; 猕猴; 图 1a
贝克曼库尔特实验系统(苏州)有限公司HLA-DR抗体(Beckman Coulter, IMMU-157)被用于被用于流式细胞仪在猕猴样本上 (图 1a). AIDS (2018) ncbi
小鼠 单克隆(9-49)
  • 流式细胞仪; 人类; 1:500; 图 1a
贝克曼库尔特实验系统(苏州)有限公司HLA-DR抗体(Beckman Coulter, 6604366)被用于被用于流式细胞仪在人类样本上浓度为1:500 (图 1a). Nat Commun (2017) ncbi
小鼠 单克隆(B8.12.2)
  • 流式细胞仪; 人类; 1:100; 图 1a
贝克曼库尔特实验系统(苏州)有限公司HLA-DR抗体(Beckman Coulter, B8.12.2)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 1a). Nat Immunol (2016) ncbi
小鼠 单克隆(Immu-357)
  • 流式细胞仪; 人类; 图 1
贝克曼库尔特实验系统(苏州)有限公司HLA-DR抗体(Beckman Coulter, A74781)被用于被用于流式细胞仪在人类样本上 (图 1). Stem Cell Res Ther (2016) ncbi
小鼠 单克隆(Immu-357)
  • 流式细胞仪; common marmoset; 图 5a
贝克曼库尔特实验系统(苏州)有限公司HLA-DR抗体(Beckman-Coulter, Immu-357)被用于被用于流式细胞仪在common marmoset样本上 (图 5a). J Virol (2016) ncbi
小鼠 单克隆(Immu-357)
  • 流式细胞仪; 人类; 图 1d
贝克曼库尔特实验系统(苏州)有限公司HLA-DR抗体(Beckman, IM1639U)被用于被用于流式细胞仪在人类样本上 (图 1d). PLoS ONE (2016) ncbi
小鼠 单克隆(Immu-357)
  • 流式细胞仪; 猕猴
贝克曼库尔特实验系统(苏州)有限公司HLA-DR抗体(Beckman Coulter, Immu-357)被用于被用于流式细胞仪在猕猴样本上. PLoS Pathog (2014) ncbi
小鼠 单克隆(Immu-357)
  • 流式细胞仪; 猕猴
贝克曼库尔特实验系统(苏州)有限公司HLA-DR抗体(Beckman-Coulter, Immu-357)被用于被用于流式细胞仪在猕猴样本上. J Infect Dis (2015) ncbi
小鼠 单克隆(B8.12.2)
  • 流式细胞仪; 人类
贝克曼库尔特实验系统(苏州)有限公司HLA-DR抗体(Beckman Coulter, IM0464)被用于被用于流式细胞仪在人类样本上. J Immunol Res (2014) ncbi
小鼠 单克隆(9-49)
  • 流式细胞仪; South American squirrel monkey
贝克曼库尔特实验系统(苏州)有限公司HLA-DR抗体(Beckman, 9-49(I3))被用于被用于流式细胞仪在South American squirrel monkey样本上. J Immunol Methods (2005) ncbi
小鼠 单克隆(Immu-357)
  • 流式细胞仪; 人类
贝克曼库尔特实验系统(苏州)有限公司HLA-DR抗体(Beckman Coulter, 2659)被用于被用于流式细胞仪在人类样本上. J Immunol (2002) ncbi
碧迪BD
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类; 图 2b
碧迪BDHLA-DR抗体(BD Pharmingen, TU36)被用于被用于流式细胞仪在人类样本上 (图 2b). Oncoimmunology (2022) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 s3b
碧迪BDHLA-DR抗体(BD, G46-6)被用于被用于流式细胞仪在人类样本上 (图 s3b). Front Immunol (2021) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 3a
碧迪BDHLA-DR抗体(BD, 564040)被用于被用于流式细胞仪在人类样本上 (图 3a). Immunity (2021) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类; 图 1f
碧迪BDHLA-DR抗体(BD Biosciences, 555561)被用于被用于流式细胞仪在人类样本上 (图 1f). Cell Res (2020) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 1a, 4b
碧迪BDHLA-DR抗体(BD, G46-6)被用于被用于流式细胞仪在人类样本上 (图 1a, 4b). Rheumatology (Oxford) (2020) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; African green monkey; 图 s3a
碧迪BDHLA-DR抗体(BD Biosciences, 335796)被用于被用于流式细胞仪在African green monkey样本上 (图 s3a). PLoS Pathog (2020) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 5d
碧迪BDHLA-DR抗体(BD, 555812)被用于被用于流式细胞仪在人类样本上 (图 5d). Front Immunol (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s14b
碧迪BDHLA-DR抗体(BD Bioscience, L243)被用于被用于流式细胞仪在人类样本上 (图 s14b). Science (2019) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 s5c
碧迪BDHLA-DR抗体(BD, G46-6)被用于被用于流式细胞仪在人类样本上 (图 s5c). PLoS Pathog (2019) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 3a
碧迪BDHLA-DR抗体(BD Biosciences, L243)被用于被用于流式细胞仪在人类样本上 (图 3a). Am J Respir Crit Care Med (2019) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 小鼠
碧迪BDHLA-DR抗体(BD Biosciences, G46-6)被用于被用于流式细胞仪在小鼠样本上. Nature (2019) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 6g
碧迪BDHLA-DR抗体(BD Biosciences, 564040)被用于被用于流式细胞仪在人类样本上 (图 6g). Cell (2019) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 猕猴; 图 2d
碧迪BDHLA-DR抗体(BD Biosciences, G46-6)被用于被用于流式细胞仪在猕猴样本上 (图 2d). J Virol (2019) ncbi
单克隆(G46-6)
  • 流式细胞仪; 人类; 图 2a
碧迪BDHLA-DR抗体(BD, 564516)被用于被用于流式细胞仪在人类样本上 (图 2a). J Exp Med (2018) ncbi
单克隆(L243)
  • 免疫组化-冰冻切片; 人类; 1:100; 图 s18d
碧迪BDHLA-DR抗体(BD Biosciences, 655874)被用于被用于免疫组化-冰冻切片在人类样本上浓度为1:100 (图 s18d). Science (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 6d
碧迪BDHLA-DR抗体(BD, L243)被用于被用于流式细胞仪在人类样本上 (图 6d). Front Immunol (2018) ncbi
小鼠 单克隆(Tu39)
  • 抑制或激活实验; 人类; 图 s2b
碧迪BDHLA-DR抗体(BD Biosciences, Tu39)被用于被用于抑制或激活实验在人类样本上 (图 s2b). Nat Med (2018) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 1d
碧迪BDHLA-DR抗体(BD PharMingen, 560943)被用于被用于流式细胞仪在人类样本上 (图 1d). J Exp Med (2018) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1a
碧迪BDHLA-DR抗体(BD Biosciences, L243)被用于被用于流式细胞仪在人类样本上 (图 1a). J Immunol (2017) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 s1a
碧迪BDHLA-DR抗体(BD Biosciences, G46-6)被用于被用于流式细胞仪在人类样本上 (图 s1a). Front Immunol (2017) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 7
碧迪BDHLA-DR抗体(BD Bioscience, G46-6)被用于被用于流式细胞仪在人类样本上 (图 7). J Immunol (2017) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 5c
碧迪BDHLA-DR抗体(BD Biosciences, G46-6)被用于被用于流式细胞仪在人类样本上 (图 5c). J Immunol (2017) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 1c
碧迪BDHLA-DR抗体(BD Biosciences, G46.6)被用于被用于流式细胞仪在人类样本上 (图 1c). J Immunol (2017) ncbi
小鼠 单克隆(G46-6)
  • 其他; 人类; 图 s1
碧迪BDHLA-DR抗体(BD/Pharm, 555809)被用于被用于其他在人类样本上 (图 s1). Cell Chem Biol (2017) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 2b
碧迪BDHLA-DR抗体(BD Biosciences, G46-6)被用于被用于流式细胞仪在人类样本上 (图 2b). Sci Rep (2017) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类; 1:500; 图 s1b
碧迪BDHLA-DR抗体(BD Biosciences, 555561)被用于被用于流式细胞仪在人类样本上浓度为1:500 (图 s1b). Nat Commun (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 st1
碧迪BDHLA-DR抗体(BD, L243)被用于被用于流式细胞仪在人类样本上 (图 st1). J Exp Med (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1b
碧迪BDHLA-DR抗体(BD Biosciences, L243)被用于被用于流式细胞仪在人类样本上 (图 1b). J Immunol (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 2b
碧迪BDHLA-DR抗体(BD Biosciences, L243)被用于被用于流式细胞仪在人类样本上 (图 2b). Nature (2017) ncbi
小鼠 单克隆(G46-6)
  • 抑制或激活实验; 人类; 1 ug/ml; 图 1e
碧迪BDHLA-DR抗体(BD Biosciences, G46-6)被用于被用于抑制或激活实验在人类样本上浓度为1 ug/ml (图 1e). J Immunol (2017) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 3a
碧迪BDHLA-DR抗体(Becton Dickinson, G46-6)被用于被用于流式细胞仪在人类样本上 (图 3a). J Leukoc Biol (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1c
碧迪BDHLA-DR抗体(BD Biosciences, L243)被用于被用于流式细胞仪在人类样本上 (图 1c). Eur J Immunol (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s4
碧迪BDHLA-DR抗体(BD Biosciences, L243)被用于被用于流式细胞仪在人类样本上 (图 s4). Genome Med (2017) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD Bioscience, 556643)被用于被用于流式细胞仪在人类样本上. Mol Cell (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD Bioscience, 641393)被用于被用于流式细胞仪在人类样本上. Mol Cell (2017) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 S1a
碧迪BDHLA-DR抗体(BD, 561224)被用于被用于流式细胞仪在人类样本上 (图 S1a). Sci Rep (2017) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 s2
碧迪BDHLA-DR抗体(BD, G46-6)被用于被用于流式细胞仪在人类样本上 (图 s2). Oncoimmunology (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(Pharmingen, L243)被用于被用于流式细胞仪在人类样本上. Oncol Lett (2017) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 1a
碧迪BDHLA-DR抗体(BD Pharmingen, G46-6)被用于被用于流式细胞仪在人类样本上 (图 1a). JCI Insight (2017) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 6e
碧迪BDHLA-DR抗体(BD Bioscience, G46-6)被用于被用于流式细胞仪在人类样本上 (图 6e). Sci Rep (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 食蟹猴; 图 3d
碧迪BDHLA-DR抗体(BD Biosciences, L243)被用于被用于流式细胞仪在食蟹猴样本上 (图 3d). J Immunol (2017) ncbi
小鼠 单克隆(L243)
  • 免疫组化; 人类; 1:500
碧迪BDHLA-DR抗体(BD Biosciences, L243)被用于被用于免疫组化在人类样本上浓度为1:500. Neurology (2017) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 表 3
碧迪BDHLA-DR抗体(BD Biosciences, L243)被用于被用于流式细胞仪在人类样本上 (表 3). Am J Pathol (2017) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类; 图 4b
碧迪BDHLA-DR抗体(BD Biosciences, 555560)被用于被用于流式细胞仪在人类样本上 (图 4b). PLoS ONE (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 3a
碧迪BDHLA-DR抗体(BD, G46-6)被用于被用于流式细胞仪在人类样本上 (图 3a). PLoS ONE (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 表 s2
碧迪BDHLA-DR抗体(BD Biosciences, 561224)被用于被用于流式细胞仪在人类样本上 (表 s2). Science (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s1a
碧迪BDHLA-DR抗体(BD Biosciences, L243)被用于被用于流式细胞仪在人类样本上 (图 s1a). J Immunol (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 表 3
碧迪BDHLA-DR抗体(Becton Dickinson, G46-6)被用于被用于流式细胞仪在人类样本上 (表 3). N Biotechnol (2017) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD Biosciences, G46-6)被用于被用于流式细胞仪在人类样本上. J Immunol (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 表 3
碧迪BDHLA-DR抗体(BD Pharmingen, G46-6)被用于被用于流式细胞仪在人类样本上 (表 3). Brain Behav (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 1c
碧迪BDHLA-DR抗体(BD Biosciences, 560944)被用于被用于流式细胞仪在人类样本上 (图 1c). Mol Med Rep (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 猕猴; 图 s11b
碧迪BDHLA-DR抗体(BD Pharmingen, 552764)被用于被用于流式细胞仪在猕猴样本上 (图 s11b). Science (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 4a
碧迪BDHLA-DR抗体(BD, 560896)被用于被用于流式细胞仪在人类样本上 (图 4a). J Virol (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1a, 1c
碧迪BDHLA-DR抗体(BD Biosciences, 641393)被用于被用于流式细胞仪在人类样本上 (图 1a, 1c). JCI Insight (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 1a, 1c
碧迪BDHLA-DR抗体(BD Biosciences, 561358)被用于被用于流式细胞仪在人类样本上 (图 1a, 1c). JCI Insight (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 4b
碧迪BDHLA-DR抗体(BD Biosciences, G46-6)被用于被用于流式细胞仪在人类样本上 (图 4b). Oncotarget (2016) ncbi
小鼠 单克隆(Tu39)
  • 流式细胞仪; 人类; 图 1
碧迪BDHLA-DR抗体(BD PharMingen, 555558)被用于被用于流式细胞仪在人类样本上 (图 1). Stem Cell Reports (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 6a
碧迪BDHLA-DR抗体(Becton Dickinson, G46-6)被用于被用于流式细胞仪在人类样本上 (图 6a). J Virol (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD Biosciences, 335813)被用于被用于流式细胞仪在人类样本上. Oncoimmunology (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD PharMingen, 555812)被用于被用于流式细胞仪在人类样本上. Oncoimmunology (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 3a
碧迪BDHLA-DR抗体(BD Bioscience, G46-6)被用于被用于流式细胞仪在人类样本上 (图 3a). J Interferon Cytokine Res (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 1:1000
碧迪BDHLA-DR抗体(BD Biosciences, 560896)被用于被用于流式细胞仪在人类样本上浓度为1:1000. Oncol Lett (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 s1e
碧迪BDHLA-DR抗体(BD Biosciences, G46-6)被用于被用于流式细胞仪在人类样本上 (图 s1e). Sci Rep (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 1
碧迪BDHLA-DR抗体(BD Biosciences, 555812)被用于被用于流式细胞仪在人类样本上 (图 1). Mol Med Rep (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 6b
碧迪BDHLA-DR抗体(BD Bioscience, L243)被用于被用于流式细胞仪在人类样本上 (图 6b). Sci Rep (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1a
碧迪BDHLA-DR抗体(Becton Dickinson, L243)被用于被用于流式细胞仪在人类样本上 (图 1a). J Allergy Clin Immunol (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s4b
碧迪BDHLA-DR抗体(BD Biosciences, L243)被用于被用于流式细胞仪在人类样本上 (图 s4b). J Immunol (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 1
碧迪BDHLA-DR抗体(BD Biosciences, 556644)被用于被用于流式细胞仪在人类样本上 (图 1). Nat Commun (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD Biosciences, 335813)被用于被用于流式细胞仪在人类样本上. Oncol Lett (2016) ncbi
小鼠 单克隆(L243)
  • 免疫组化; 人类; 1:50; 图 7b
碧迪BDHLA-DR抗体(BD, 340688)被用于被用于免疫组化在人类样本上浓度为1:50 (图 7b). J Clin Invest (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 2
碧迪BDHLA-DR抗体(BD Biosciences, L243)被用于被用于流式细胞仪在人类样本上 (图 2). Cytotherapy (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 2a
碧迪BDHLA-DR抗体(BD Biosciences, G46-6)被用于被用于流式细胞仪在人类样本上 (图 2a). Eur J Immunol (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 3b
碧迪BDHLA-DR抗体(BD Biosciences, L243)被用于被用于流式细胞仪在人类样本上 (图 3b). J Immunol (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 1
碧迪BDHLA-DR抗体(BD Biosciences, G46-6)被用于被用于流式细胞仪在人类样本上 (图 1). J Transl Med (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; African green monkey; 图 2b
碧迪BDHLA-DR抗体(BD, L 243)被用于被用于流式细胞仪在African green monkey样本上 (图 2b). J Med Primatol (2016) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类; 图 2
碧迪BDHLA-DR抗体(BD Pharmingen, TU36)被用于被用于流式细胞仪在人类样本上 (图 2). J Leukoc Biol (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 1:200; 图 7j
碧迪BDHLA-DR抗体(BD Biosciences, G46-6)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 7j). Nat Commun (2016) ncbi
小鼠 单克隆(Tu39)
  • 流式细胞仪; 人类; 1:200; 图 1
碧迪BDHLA-DR抗体(BD Biosciences, 555558)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 1). Oncoimmunology (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 1:100; 图 5
碧迪BDHLA-DR抗体(BD PharMingen, 561224)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 5). Oncoimmunology (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 7a
碧迪BDHLA-DR抗体(BD Biosciences, G46-6)被用于被用于流式细胞仪在人类样本上 (图 7a). PLoS ONE (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD Biosciences, L243)被用于被用于流式细胞仪在人类样本上. Clin Immunol (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 表 2
碧迪BDHLA-DR抗体(BD Biosciences, 559866)被用于被用于流式细胞仪在人类样本上 (表 2). Vet Parasitol (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 1
碧迪BDHLA-DR抗体(BD Biosciences, 555811)被用于被用于流式细胞仪在人类样本上 (图 1). Int J Mol Med (2016) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类; 图 st1
碧迪BDHLA-DR抗体(BD, 555561)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 2
碧迪BDHLA-DR抗体(BD, 347364)被用于被用于流式细胞仪在人类样本上 (图 2). Oncoimmunology (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 5b
碧迪BDHLA-DR抗体(Becton Dickinson-Pharmingen, LD43)被用于被用于流式细胞仪在人类样本上 (图 5b). Cell Immunol (2016) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类; 图 7c
碧迪BDHLA-DR抗体(BD Bioscience, TU36)被用于被用于流式细胞仪在人类样本上 (图 7c). PLoS ONE (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 猕猴; 图 s2
碧迪BDHLA-DR抗体(BD Biosciences Pharmingen, L243)被用于被用于流式细胞仪在猕猴样本上 (图 s2). Mucosal Immunol (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 1:40; 图 2
碧迪BDHLA-DR抗体(BD Horizon, G46-6)被用于被用于流式细胞仪在人类样本上浓度为1:40 (图 2). Nat Commun (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 5
碧迪BDHLA-DR抗体(BD Bioscience, G46-6)被用于被用于流式细胞仪在人类样本上 (图 5). Sci Rep (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s7
碧迪BDHLA-DR抗体(BD Biosciences, 641393)被用于被用于流式细胞仪在人类样本上 (图 s7). PLoS ONE (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 S1A
碧迪BDHLA-DR抗体(BD, G46-6)被用于被用于流式细胞仪在人类样本上 (图 S1A). J Immunol (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 2a
碧迪BDHLA-DR抗体(BD Pharmingen, 560943)被用于被用于流式细胞仪在人类样本上 (图 2a). Mol Med Rep (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 表 1
碧迪BDHLA-DR抗体(Becton Dickinson, L243)被用于被用于流式细胞仪在人类样本上 (表 1). J Transl Med (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 猕猴
碧迪BDHLA-DR抗体(BD Biosciences, L243)被用于被用于流式细胞仪在猕猴样本上. PLoS ONE (2015) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类; 图 1c
碧迪BDHLA-DR抗体(BD Biosciences, TU36)被用于被用于流式细胞仪在人类样本上 (图 1c). Cytotherapy (2016) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 猕猴
碧迪BDHLA-DR抗体(BD Biosciences, L243)被用于被用于流式细胞仪在猕猴样本上. Clin Exp Immunol (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 s3
碧迪BDHLA-DR抗体(BD Biosciences, G46-6)被用于被用于流式细胞仪在人类样本上 (图 s3). Sci Transl Med (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 4
碧迪BDHLA-DR抗体(BD, 340691)被用于被用于流式细胞仪在人类样本上 (图 4). Nat Commun (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 7
碧迪BDHLA-DR抗体(BD Biosciences, L243)被用于被用于流式细胞仪在人类样本上 (图 7). Eur J Immunol (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 猕猴
碧迪BDHLA-DR抗体(BD, 552764)被用于被用于流式细胞仪在猕猴样本上. PLoS ONE (2015) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 2i
碧迪BDHLA-DR抗体(BD Biosciences, G46-6)被用于被用于流式细胞仪在人类样本上 (图 2i). J Immunol (2015) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 小鼠; 图 s2d
碧迪BDHLA-DR抗体(BD Pharmingen, G46-6)被用于被用于流式细胞仪在小鼠样本上 (图 s2d). Nat Chem Biol (2015) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 e4b
碧迪BDHLA-DR抗体(BD Biosciences, G46-6)被用于被用于流式细胞仪在人类样本上 (图 e4b). J Allergy Clin Immunol (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 猫; 1:50; 表 3
碧迪BDHLA-DR抗体(BD Biosciences,, 555810)被用于被用于流式细胞仪在猫样本上浓度为1:50 (表 3). Cell Reprogram (2015) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类; 表 1
碧迪BDHLA-DR抗体(BD bioscience, 555561)被用于被用于流式细胞仪在人类样本上 (表 1). PLoS ONE (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 s5
碧迪BDHLA-DR抗体(BD Biosciences, L243)被用于被用于流式细胞仪在人类样本上 (图 s5). PLoS Pathog (2015) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 2
碧迪BDHLA-DR抗体(BD Biosciences, 560652)被用于被用于流式细胞仪在人类样本上 (图 2). Stem Cell Res Ther (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; marmosets
碧迪BDHLA-DR抗体(BD Biosciences, L243)被用于被用于流式细胞仪在marmosets样本上. J Neuroimmune Pharmacol (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 2
碧迪BDHLA-DR抗体(BD Biosciences, 561224)被用于被用于流式细胞仪在人类样本上 (图 2). J Endod (2015) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 2
碧迪BDHLA-DR抗体(BD Biosciences, 555810)被用于被用于流式细胞仪在人类样本上 (图 2). Int J Mol Med (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 表 1
碧迪BDHLA-DR抗体(BD, L243)被用于被用于流式细胞仪在人类样本上 (表 1). Cytometry B Clin Cytom (2016) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD Biosciences, 559866)被用于被用于流式细胞仪在人类样本上. J Tissue Eng Regen Med (2017) ncbi
小鼠 单克隆(TU36)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD Biosciences, 555561)被用于被用于流式细胞仪在人类样本上. Nat Genet (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 表 4
碧迪BDHLA-DR抗体(BD Bioscience, L243)被用于被用于流式细胞仪在人类样本上 (表 4). Cytometry B Clin Cytom (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 2
碧迪BDHLA-DR抗体(BD Pharmingen, L243)被用于被用于流式细胞仪在人类样本上 (图 2). PLoS ONE (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; African green monkey
碧迪BDHLA-DR抗体(BD Biosciences, L243)被用于被用于流式细胞仪在African green monkey样本上. J Infect Dis (2015) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD Biosciences, G46-6)被用于被用于流式细胞仪在人类样本上. J Infect Dis (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 1a
碧迪BDHLA-DR抗体(BD Biosciences, L243)被用于被用于流式细胞仪在人类样本上 (图 1a). J Immunol (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 3b
碧迪BDHLA-DR抗体(BD Pharmingen, L243)被用于被用于流式细胞仪在人类样本上 (图 3b). Front Immunol (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD Biosciences, L243)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2015) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 2
  • 免疫细胞化学; 人类; 图 1
碧迪BDHLA-DR抗体(BD Pharmingen, G46-6)被用于被用于流式细胞仪在人类样本上 (图 2) 和 被用于免疫细胞化学在人类样本上 (图 1). Immunol Cell Biol (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 2
碧迪BDHLA-DR抗体(BD Biosciences, L243)被用于被用于流式细胞仪在人类样本上 (图 2). Immunol Cell Biol (2015) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 表 s1
碧迪BDHLA-DR抗体(BD Biosciences, G46-6)被用于被用于流式细胞仪在人类样本上 (表 s1). Proc Natl Acad Sci U S A (2015) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 3
碧迪BDHLA-DR抗体(BD, G46-6)被用于被用于流式细胞仪在人类样本上 (图 3). J Exp Med (2015) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 2
碧迪BDHLA-DR抗体(BD Biosciences, G46-6)被用于被用于流式细胞仪在人类样本上 (图 2). J Autoimmun (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 表 s5
碧迪BDHLA-DR抗体(BD Bioscience, L243)被用于被用于流式细胞仪在人类样本上 (表 s5). Proc Natl Acad Sci U S A (2015) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 st3
碧迪BDHLA-DR抗体(BD Biosciences, L243)被用于被用于流式细胞仪在人类样本上 (图 st3). AIDS (2015) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD Pharmingen, G46-6)被用于被用于流式细胞仪在人类样本上. Clin Cancer Res (2015) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD Pharmingen, 559866)被用于被用于流式细胞仪在人类样本上. Alcohol (2015) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD Biosciences, G46-6)被用于被用于流式细胞仪在人类样本上. Immun Inflamm Dis (2014) ncbi
小鼠 单克隆(Tu39)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD, Tu39)被用于被用于流式细胞仪在人类样本上. Hum Immunol (2014) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 表 1
碧迪BDHLA-DR抗体(BD Biosciences, 555812)被用于被用于流式细胞仪在人类样本上 (表 1). Exp Ther Med (2015) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 1:5
碧迪BDHLA-DR抗体(BD Biosciences, G46-6)被用于被用于流式细胞仪在人类样本上浓度为1:5. Nat Commun (2014) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD Biosciences, G46-6)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 2
碧迪BDHLA-DR抗体(Becton Dickinson, G46-6)被用于被用于流式细胞仪在人类样本上 (图 2). Blood (2015) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 4
碧迪BDHLA-DR抗体(BD Biosciences, G46-6)被用于被用于流式细胞仪在人类样本上 (图 4). Immunol Cell Biol (2015) ncbi
小鼠 单克隆(Tu39)
  • 流式细胞仪; 人类; 图 1
碧迪BDHLA-DR抗体(BD Biosciences, 555558)被用于被用于流式细胞仪在人类样本上 (图 1). Methods Mol Biol (2015) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD Biosciences, G46-6)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(G46-6)
  • 免疫组化-石蜡切片; 人类; 1:100
碧迪BDHLA-DR抗体(BD Biosciences, 555811)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100. Mol Med Rep (2015) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD Biosciences, G46-6)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD, G46-6)被用于被用于流式细胞仪在人类样本上. PLoS Negl Trop Dis (2014) ncbi
小鼠 单克隆(TU36)
  • 免疫细胞化学; 小鼠
碧迪BDHLA-DR抗体(PharMingen, TU36)被用于被用于免疫细胞化学在小鼠样本上. Hum Pathol (2014) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(Becton Dickenson, G46-6)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD Biosciences, L243)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD Biosciences, G46-6)被用于被用于流式细胞仪在人类样本上. Clin Exp Allergy (2014) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD Biosciences, G46-6)被用于被用于流式细胞仪在人类样本上. Blood (2014) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD Bioscience, G46)被用于被用于流式细胞仪在人类样本上. PLoS Pathog (2014) ncbi
小鼠 单克隆(G46-6)
  • 免疫沉淀; 人类
  • 免疫印迹; 人类
碧迪BDHLA-DR抗体(BD Pharmingen, 347401)被用于被用于免疫沉淀在人类样本上 和 被用于免疫印迹在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; African green monkey; 图 s1
碧迪BDHLA-DR抗体(BD Biosciences, L243)被用于被用于流式细胞仪在African green monkey样本上 (图 s1). PLoS Pathog (2014) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 s1b
碧迪BDHLA-DR抗体(BD Biosciences, 555812)被用于被用于流式细胞仪在人类样本上 (图 s1b). Oncotarget (2014) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(Becton Dickinson Pharmingen, 555811)被用于被用于流式细胞仪在人类样本上. J Immunol Methods (2014) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD Biosciences, G46-6)被用于被用于流式细胞仪在人类样本上. J Infect Dis (2014) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD Biosciences, G46)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD Bioscience, clone L243)被用于被用于流式细胞仪在人类样本上. Mol Ther (2014) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD Horizon, 561359)被用于被用于流式细胞仪在人类样本上. J Inflamm (Lond) (2014) ncbi
小鼠 单克隆(Tu39)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD Biosciences, Tu39)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 黑猩猩
碧迪BDHLA-DR抗体(BD Biosciences, G46-6/L243)被用于被用于流式细胞仪在黑猩猩样本上. J Med Primatol (2014) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 黑猩猩
碧迪BDHLA-DR抗体(BD Biosciences, G46-6/L243)被用于被用于流式细胞仪在黑猩猩样本上. J Med Primatol (2014) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(Becton-Dickinson Pharmingen, L243)被用于被用于流式细胞仪在人类样本上. Nanomedicine (2014) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD Biosciences, G46-6)被用于被用于流式细胞仪在人类样本上. Mol Immunol (2014) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 1
碧迪BDHLA-DR抗体(BD, G46-6)被用于被用于流式细胞仪在人类样本上 (图 1). Cancer Immunol Immunother (2014) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD, L243)被用于被用于流式细胞仪在人类样本上. Cytometry A (2014) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 图 4B
碧迪BDHLA-DR抗体(BD, G46-6)被用于被用于流式细胞仪在人类样本上 (图 4B). J Immunol (2014) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD Biosciences, 347367)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2013) ncbi
小鼠 单克隆(Tu39)
  • 流式细胞仪; 人类; 1:200
碧迪BDHLA-DR抗体(BD, 555557)被用于被用于流式细胞仪在人类样本上浓度为1:200. PLoS ONE (2013) ncbi
小鼠 单克隆(Tu39)
  • 免疫组化; 人类
碧迪BDHLA-DR抗体(BD, TU39)被用于被用于免疫组化在人类样本上. Development (2013) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD, 560651)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2012) ncbi
小鼠 单克隆(G46-6)
  • 流式细胞仪; 人类; 1:5
碧迪BDHLA-DR抗体(BD Pharmingen, G46-6)被用于被用于流式细胞仪在人类样本上浓度为1:5. Microvasc Res (2012) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类
碧迪BDHLA-DR抗体(BD, 347364)被用于被用于流式细胞仪在人类样本上. Nat Protoc (2010) ncbi
小鼠 单克隆(L243)
  • 流式细胞仪; 人类; 图 6
碧迪BDHLA-DR抗体(BD Biosciences, L243)被用于被用于流式细胞仪在人类样本上 (图 6). Blood (2007) ncbi
文章列表
  1. Ye Y, Zhang X, Su D, Ren Y, Cheng F, Yao Y, et al. Therapeutic efficacy of human adipose mesenchymal stem cells in Crohn's colon fibrosis is improved by IFN-γ and kynurenic acid priming through indoleamine 2,3-dioxygenase-1 signaling. Stem Cell Res Ther. 2022;13:465 pubmed 出版商
  2. Amaral E, Foreman T, Namasivayam S, Hilligan K, Kauffman K, Barbosa Bomfim C, et al. GPX4 regulates cellular necrosis and host resistance in Mycobacterium tuberculosis infection. J Exp Med. 2022;219: pubmed 出版商
  3. Brown G, Ca xf1 ete P, Wang H, Medhavy A, Bones J, Roco J, et al. TLR7 gain-of-function genetic variation causes human lupus. Nature. 2022;605:349-356 pubmed 出版商
  4. van der Heide V, Jangra S, Cohen P, Rathnasinghe R, Aslam S, Aydillo T, et al. Limited extent and consequences of pancreatic SARS-CoV-2 infection. Cell Rep. 2022;38:110508 pubmed 出版商
  5. Kono M, Komatsuda H, Yamaki H, Kumai T, Hayashi R, Wakisaka R, et al. Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma. Oncoimmunology. 2022;11:2021619 pubmed 出版商
  6. Liu Y, Wang L, Song Q, Ali M, Crowe W, Kucera G, et al. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion. Nat Nanotechnol. 2022;17:206-216 pubmed 出版商
  7. Qian S, Huang Q, Chen R, Mo J, Zhou L, Zhao Y, et al. Single-Cell RNA Sequencing Identifies New Inflammation-Promoting Cell Subsets in Asian Patients With Chronic Periodontitis. Front Immunol. 2021;12:711337 pubmed 出版商
  8. Moreira T, Mangani D, Cox L, Leibowitz J, Lobo E, Oliveira M, et al. PD-L1+ and XCR1+ dendritic cells are region-specific regulators of gut homeostasis. Nat Commun. 2021;12:4907 pubmed 出版商
  9. Su C, Lu F, Soldan S, Lamontagne R, Tang H, Napoletani G, et al. EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytes. PLoS Pathog. 2021;17:e1009834 pubmed 出版商
  10. Claes C, Danhash E, Hasselmann J, Chadarevian J, Shabestari S, England W, et al. Plaque-associated human microglia accumulate lipid droplets in a chimeric model of Alzheimer's disease. Mol Neurodegener. 2021;16:50 pubmed 出版商
  11. Li Y, Shi G, Han Y, Shang H, Li H, Liang W, et al. Therapeutic potential of human umbilical cord mesenchymal stem cells on aortic atherosclerotic plaque in a high-fat diet rabbit model. Stem Cell Res Ther. 2021;12:407 pubmed 出版商
  12. Lu Q, Liu J, Zhao S, Gomez Castro M, Laurent Rolle M, Dong J, et al. SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2. Immunity. 2021;54:1304-1319.e9 pubmed 出版商
  13. Borggrewe M, Kooistra S, Wesseling E, Gierschek F, Brummer M, Nowak E, et al. VISTA regulates microglia homeostasis and myelin phagocytosis, and is associated with MS lesion pathology. Acta Neuropathol Commun. 2021;9:91 pubmed 出版商
  14. Reis M, Willis G, Fernandez Gonzalez A, Yeung V, Taglauer E, Magaletta M, et al. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Restore Thymic Architecture and T Cell Function Disrupted by Neonatal Hyperoxia. Front Immunol. 2021;12:640595 pubmed 出版商
  15. Garcia Mesa Y, Xu H, Vance P, Gruenewald A, Garza R, Midkiff C, et al. Dimethyl Fumarate, an Approved Multiple Sclerosis Treatment, Reduces Brain Oxidative Stress in SIV-Infected Rhesus Macaques: Potential Therapeutic Repurposing for HIV Neuroprotection. Antioxidants (Basel). 2021;10: pubmed 出版商
  16. Ingelfinger F, Krishnarajah S, Kramer M, Utz S, Galli E, Lutz M, et al. Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature. Acta Neuropathol. 2021;141:901-915 pubmed 出版商
  17. Szabo P, Dogra P, Gray J, Wells S, Connors T, Weisberg S, et al. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity. 2021;54:797-814.e6 pubmed 出版商
  18. Chiou S, Tseng D, Reuben A, Mallajosyula V, Molina I, Conley S, et al. Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery. Immunity. 2021;54:586-602.e8 pubmed 出版商
  19. Khosravi Maharlooei M, Li H, Hoelzl M, Zhao G, Ruiz A, Misra A, et al. Role of the thymus in spontaneous development of a multi-organ autoimmune disease in human immune system mice. J Autoimmun. 2021;119:102612 pubmed 出版商
  20. Fletcher R, Tong J, Risnik D, Leibowitz B, Wang Y, Concha Benavente F, et al. Non-steroidal anti-inflammatory drugs induce immunogenic cell death in suppressing colorectal tumorigenesis. Oncogene. 2021;40:2035-2050 pubmed 出版商
  21. Xu L, Zu T, Li T, Li M, Mi J, Bai F, et al. ATF3 downmodulates its new targets IFI6 and IFI27 to suppress the growth and migration of tongue squamous cell carcinoma cells. PLoS Genet. 2021;17:e1009283 pubmed 出版商
  22. Gregorova M, Morse D, Brignoli T, Steventon J, Hamilton F, Albur M, et al. Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia. elife. 2020;9: pubmed 出版商
  23. Rodda L, Netland J, Shehata L, Pruner K, Morawski P, Thouvenel C, et al. Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19. Cell. 2021;184:169-183.e17 pubmed 出版商
  24. Noz M, Bekkering S, Groh L, Nielen T, Lamfers E, Schlitzer A, et al. Reprogramming of bone marrow myeloid progenitor cells in patients with severe coronary artery disease. elife. 2020;9: pubmed 出版商
  25. Rohr S, Greiner T, Joost S, Amor S, Valk P, Schmitz C, et al. Aquaporin-4 Expression during Toxic and Autoimmune Demyelination. Cells. 2020;9: pubmed 出版商
  26. Neidleman J, Luo X, Frouard J, Xie G, Hsiao F, Ma T, et al. Phenotypic analysis of the unstimulated in vivo HIV CD4 T cell reservoir. elife. 2020;9: pubmed 出版商
  27. Stary V, Wolf B, Unterleuthner D, List J, Talic M, Laengle J, et al. Short-course radiotherapy promotes pro-inflammatory macrophages via extracellular vesicles in human rectal cancer. J Immunother Cancer. 2020;8: pubmed 出版商
  28. Pasciuto E, Burton O, Roca C, Lagou V, Rajan W, Theys T, et al. Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition. Cell. 2020;182:625-640.e24 pubmed 出版商
  29. Morrissey M, Byrne R, Nulty C, McCabe N, Lynam Lennon N, Butler C, et al. The tumour microenvironment of the upper and lower gastrointestinal tract differentially influences dendritic cell maturation. BMC Cancer. 2020;20:566 pubmed 出版商
  30. Wu J, Song D, Li Z, Guo B, Xiao Y, Liu W, et al. Immunity-and-matrix-regulatory cells derived from human embryonic stem cells safely and effectively treat mouse lung injury and fibrosis. Cell Res. 2020;30:794-809 pubmed 出版商
  31. Ma T, Luo X, George A, Mukherjee G, Sen N, Spitzer T, et al. HIV efficiently infects T cells from the endometrium and remodels them to promote systemic viral spread. elife. 2020;9: pubmed 出版商
  32. Chandrashekar A, Liu J, Martinot A, McMahan K, Mercado N, Peter L, et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. 2020;: pubmed 出版商
  33. Kim J, Jeong J, Jung J, Jeon H, Lee S, Lim J, et al. Immunological characteristics and possible pathogenic role of urinary CD11c+ macrophages in lupus nephritis. Rheumatology (Oxford). 2020;: pubmed 出版商
  34. Raehtz K, Barrenas F, Xu C, Busman Sahay K, Valentine A, Law L, et al. African green monkeys avoid SIV disease progression by preventing intestinal dysfunction and maintaining mucosal barrier integrity. PLoS Pathog. 2020;16:e1008333 pubmed 出版商
  35. Park J, Botting R, Domínguez Conde C, Popescu D, Lavaert M, Kunz D, et al. A cell atlas of human thymic development defines T cell repertoire formation. Science. 2020;367: pubmed 出版商
  36. Trus I, Udenze D, Bérubé N, Wheler C, Martel M, Gerdts V, et al. CpG-Recoding in Zika Virus Genome Causes Host-Age-Dependent Attenuation of Infection With Protection Against Lethal Heterologous Challenge in Mice. Front Immunol. 2019;10:3077 pubmed 出版商
  37. Theivanthiran B, Evans K, Devito N, Plebanek M, Sturdivant M, Wachsmuth L, et al. A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti-PD-1 immunotherapy. J Clin Invest. 2020;130:2570-2586 pubmed 出版商
  38. Mosaheb M, Dobrikova E, Brown M, Yang Y, Cable J, Okada H, et al. Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity. Nat Commun. 2020;11:524 pubmed 出版商
  39. Helmink B, Reddy S, Gao J, Zhang S, Basar R, Thakur R, et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020;577:549-555 pubmed 出版商
  40. Uhlen M, Karlsson M, Zhong W, Tebani A, Pou C, Mikes J, et al. A genome-wide transcriptomic analysis of protein-coding genes in human blood cells. Science. 2019;366: pubmed 出版商
  41. Raphael I, Gomez Rivera F, Raphael R, Robinson R, Nalawade S, Forsthuber T. TNFR2 limits proinflammatory astrocyte functions during EAE induced by pathogenic DR2b-restricted T cells. JCI Insight. 2019;4: pubmed 出版商
  42. Leylek R, Alcántara Hernández M, Lanzar Z, Lüdtke A, Perez O, Reizis B, et al. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Rep. 2019;29:3736-3750.e8 pubmed 出版商
  43. Guo P, Li L, Li W, Zhao J, Hu F, Zhang F, et al. The clinical significance of myeloid-derived suppressor cells in dengue fever patients. BMC Infect Dis. 2019;19:926 pubmed 出版商
  44. Yan D, Wang J, Sun H, Zamani A, Zhang H, Chen W, et al. TIPE2 specifies the functional polarization of myeloid-derived suppressor cells during tumorigenesis. J Exp Med. 2020;217: pubmed 出版商
  45. Stewart B, Ferdinand J, Young M, Mitchell T, Loudon K, Riding A, et al. Spatiotemporal immune zonation of the human kidney. Science. 2019;365:1461-1466 pubmed 出版商
  46. Ramachandran P, Dobie R, Wilson Kanamori J, Dora E, Henderson B, Luu N, et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature. 2019;575:512-518 pubmed 出版商
  47. Merola J, Reschke M, Pierce R, Qin L, Spindler S, Baltazar T, et al. Progenitor-derived human endothelial cells evade alloimmunity by CRISPR/Cas9-mediated complete ablation of MHC expression. JCI Insight. 2019;4: pubmed 出版商
  48. Dutertre C, Becht E, Irac S, Khalilnezhad A, Narang V, Khalilnezhad S, et al. Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells. Immunity. 2019;51:573-589.e8 pubmed 出版商
  49. Martin J, Chang C, Boschetti G, Ungaro R, Giri M, Grout J, et al. Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy. Cell. 2019;178:1493-1508.e20 pubmed 出版商
  50. Saliba D, Céspedes Donoso P, Balint S, Compeer E, Korobchevskaya K, Valvo S, et al. Composition and structure of synaptic ectosomes exporting antigen receptor linked to functional CD40 ligand from helper T cells. elife. 2019;8: pubmed 出版商
  51. Di Blasi D, Boldanova T, Mori L, Terracciano L, Heim M, De Libero G. Unique T-Cell Populations Define Immune-Inflamed Hepatocellular Carcinoma. Cell Mol Gastroenterol Hepatol. 2020;9:195-218 pubmed 出版商
  52. Findlay E, Currie A, Zhang A, Ovciarikova J, Young L, Stevens H, et al. Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy. Oncoimmunology. 2019;8:1608106 pubmed 出版商
  53. Banga R, Rebecchini C, Procopio F, Noto A, Munoz O, Ioannidou K, et al. Lymph node migratory dendritic cells modulate HIV-1 transcription through PD-1 engagement. PLoS Pathog. 2019;15:e1007918 pubmed 出版商
  54. Dumont A, de Rosny C, Kieu T, Perrey S, Berger H, Fluckiger A, et al. Docosahexaenoic acid inhibits both NLRP3 inflammasome assembly and JNK-mediated mature IL-1β secretion in 5-fluorouracil-treated MDSC: implication in cancer treatment. Cell Death Dis. 2019;10:485 pubmed 出版商
  55. Xia Y, Gao Y, Wang B, Zhang H, Zhang Q. Optimizing the Method of Cell Separation from Bile of Patients with Cholangiocarcinoma for Flow Cytometry. Gastroenterol Res Pract. 2019;2019:5436961 pubmed 出版商
  56. Celis Gutierrez J, Blattmann P, Zhai Y, Jarmuzynski N, Ruminski K, Gregoire C, et al. Quantitative Interactomics in Primary T Cells Provides a Rationale for Concomitant PD-1 and BTLA Coinhibitor Blockade in Cancer Immunotherapy. Cell Rep. 2019;27:3315-3330.e7 pubmed 出版商
  57. Dangaj D, Bruand M, Grimm A, Ronet C, Barras D, Duttagupta P, et al. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors. Cancer Cell. 2019;35:885-900.e10 pubmed 出版商
  58. Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck W, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;: pubmed 出版商
  59. Swaims Kohlmeier A, Haddad L, Li Z, Brookmeyer K, Baker J, Widom C, et al. Chronic immune barrier dysregulation among women with a history of violence victimization. JCI Insight. 2019;4: pubmed 出版商
  60. Allden S, Ogger P, Ghai P, McErlean P, Hewitt R, Toshner R, et al. The Transferrin Receptor CD71 Delineates Functionally Distinct Airway Macrophage Subsets during Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2019;: pubmed 出版商
  61. Fernandez I, Baxter R, Garcia Perez J, Vendrame E, Ranganath T, Kong D, et al. A novel human IL2RB mutation results in T and NK cell-driven immune dysregulation. J Exp Med. 2019;216:1255-1267 pubmed 出版商
  62. Zhang J, Supakorndej T, Krambs J, Rao M, Abou Ezzi G, Ye R, et al. Bone marrow dendritic cells regulate hematopoietic stem/progenitor cell trafficking. J Clin Invest. 2019;129:2920-2931 pubmed 出版商
  63. Terahara K, Iwabuchi R, Hosokawa M, Nishikawa Y, Takeyama H, Takahashi Y, et al. A CCR5+ memory subset within HIV-1-infected primary resting CD4+ T cells is permissive for replication-competent, latently infected viruses in vitro. BMC Res Notes. 2019;12:242 pubmed 出版商
  64. Veglia F, Tyurin V, Blasi M, De Leo A, Kossenkov A, Donthireddy L, et al. Fatty acid transport protein 2 reprograms neutrophils in cancer. Nature. 2019;569:73-78 pubmed 出版商
  65. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed 出版商
  66. Binnewies M, Mujal A, Pollack J, Combes A, Hardison E, Barry K, et al. Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity. Cell. 2019;177:556-571.e16 pubmed 出版商
  67. Cassetta L, Fragkogianni S, Sims A, Swierczak A, Forrester L, Zhang H, et al. Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets. Cancer Cell. 2019;35:588-602.e10 pubmed 出版商
  68. Sweere J, Van Belleghem J, Ishak H, Bach M, Popescu M, Sunkari V, et al. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. Science. 2019;363: pubmed 出版商
  69. Chakarov S, Lim H, Tan L, Lim S, See P, Lum J, et al. Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches. Science. 2019;363: pubmed 出版商
  70. Crippa S, Rossella V, Aprile A, Silvestri L, Rivis S, Scaramuzza S, et al. Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity. J Clin Invest. 2019;129:1566-1580 pubmed 出版商
  71. Georgouli M, Herraiz C, Crosas Molist E, Fanshawe B, Maiques O, Perdrix A, et al. Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment. Cell. 2019;176:757-774.e23 pubmed 出版商
  72. Jin Y, Roberts G, Ferrara T, Ben S, van Geel N, Wolkerstorfer A, et al. Early-onset autoimmune vitiligo associated with an enhancer variant haplotype that upregulates class II HLA expression. Nat Commun. 2019;10:391 pubmed 出版商
  73. Alam M, Yang D, Trivett A, Meyer T, Oppenheim J. HMGN1 and R848 Synergistically Activate Dendritic Cells Using Multiple Signaling Pathways. Front Immunol. 2018;9:2982 pubmed 出版商
  74. Richardson J, Armbruster N, Günter M, Henes J, Autenrieth S. Staphylococcus aureus PSM Peptides Modulate Human Monocyte-Derived Dendritic Cells to Prime Regulatory T Cells. Front Immunol. 2018;9:2603 pubmed 出版商
  75. Jones G, Bain C, Fenton T, Kelly A, Brown S, Ivens A, et al. Dynamics of Colon Monocyte and Macrophage Activation During Colitis. Front Immunol. 2018;9:2764 pubmed 出版商
  76. Chea L, Wyatt L, Gangadhara S, Moss B, Amara R. Novel Modified Vaccinia Virus Ankara Vector Expressing Anti-apoptotic Gene B13R Delays Apoptosis and Enhances Humoral Responses. J Virol. 2019;93: pubmed 出版商
  77. Ding L, Kim H, Wang Q, Kearns M, Jiang T, Ohlson C, et al. PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer. Cell Rep. 2018;25:2972-2980.e5 pubmed 出版商
  78. Poncette L, Chen X, Lorenz F, Blankenstein T. Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression. J Clin Invest. 2019;129:324-335 pubmed 出版商
  79. Perciani C, Farah B, Kaul R, Ostrowski M, Mahmud S, Anzala O, et al. Live attenuated varicella-zoster virus vaccine does not induce HIV target cell activation. J Clin Invest. 2019;129:875-886 pubmed 出版商
  80. Kelly A, Günaltay S, McEntee C, Shuttleworth E, Smedley C, Houston S, et al. Human monocytes and macrophages regulate immune tolerance via integrin αvβ8-mediated TGFβ activation. J Exp Med. 2018;215:2725-2736 pubmed 出版商
  81. Otsuka Y, Watanabe E, Shinya E, Okura S, Saeki H, Geijtenbeek T, et al. Differentiation of Langerhans Cells from Monocytes and Their Specific Function in Inducing IL-22-Specific Th Cells. J Immunol. 2018;201:3006-3016 pubmed 出版商
  82. Olin A, Henckel E, Chen Y, Lakshmikanth T, Pou C, Mikes J, et al. Stereotypic Immune System Development in Newborn Children. Cell. 2018;174:1277-1292.e14 pubmed 出版商
  83. Kong X, Martinez Barricarte R, Kennedy J, Mele F, Lazarov T, Deenick E, et al. Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. Nat Immunol. 2018;19:973-985 pubmed 出版商
  84. Walwyn Brown K, Guldevall K, Saeed M, Pende D, Önfelt B, MacDonald A, et al. Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1. J Immunol. 2018;201:2028-2041 pubmed 出版商
  85. Young M, Mitchell T, Vieira Braga F, Tran M, Stewart B, Ferdinand J, et al. Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors. Science. 2018;361:594-599 pubmed 出版商
  86. Cooper G, Ostridge K, Khakoo S, Wilkinson T, Staples K. Human CD49a+ Lung Natural Killer Cell Cytotoxicity in Response to Influenza A Virus. Front Immunol. 2018;9:1671 pubmed 出版商
  87. Gorter R, Nutma E, Jahrei M, de Jonge J, Quinlan R, van der Valk P, et al. Heat shock proteins are differentially expressed in brain and spinal cord: implications for multiple sclerosis. Clin Exp Immunol. 2018;194:137-152 pubmed 出版商
  88. Arnold I, Artola Borán M, Tallón de Lara P, Kyburz A, Taube C, OTTEMANN K, et al. Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation. J Exp Med. 2018;215:2055-2072 pubmed 出版商
  89. Alissafi T, Hatzioannou A, Mintzas K, Barouni R, Banos A, Sormendi S, et al. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells. J Clin Invest. 2018;128:3840-3852 pubmed 出版商
  90. Dumbovic G, Biayna J, Banús J, Samuelsson J, Roth A, Diederichs S, et al. A novel long non-coding RNA from NBL2 pericentromeric macrosatellite forms a perinucleolar aggregate structure in colon cancer. Nucleic Acids Res. 2018;46:5504-5524 pubmed 出版商
  91. Luo N, Formisano L, Gonzalez Ericsson P, Sanchez V, Dean P, Opalenik S, et al. Melanoma response to anti-PD-L1 immunotherapy requires JAK1 signaling, but not JAK2. Oncoimmunology. 2018;7:e1438106 pubmed 出版商
  92. Zacharakis N, Chinnasamy H, Black M, Xu H, Lu Y, Zheng Z, et al. Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer. Nat Med. 2018;24:724-730 pubmed 出版商
  93. Mitchell K, Barreyro L, Todorova T, Taylor S, Antony Debré I, Narayanagari S, et al. IL1RAP potentiates multiple oncogenic signaling pathways in AML. J Exp Med. 2018;215:1709-1727 pubmed 出版商
  94. Manickam C, Nwanze C, Ram D, Shah S, Smith S, Jones R, et al. Progressive lentivirus infection induces natural killer cell receptor-expressing B cells in the gastrointestinal tract. AIDS. 2018;32:1571-1578 pubmed 出版商
  95. Melo Gonzalez F, Fenton T, Forss C, Smedley C, Goenka A, MacDonald A, et al. Intestinal mucin activates human dendritic cells and IL-8 production in a glycan-specific manner. J Biol Chem. 2018;293:8543-8553 pubmed 出版商
  96. Li M, Zhang W, Liu J, Li M, Zhang Y, Xiong Y, et al. Dynamic changes in the immunological characteristics of T lymphocytes in surviving patients with severe fever with thrombocytopenia syndrome (SFTS). Int J Infect Dis. 2018;70:72-80 pubmed 出版商
  97. Liu R, Merola J, Manes T, Qin L, Tietjen G, Lopez Giraldez F, et al. Interferon-γ converts human microvascular pericytes into negative regulators of alloimmunity through induction of indoleamine 2,3-dioxygenase 1. JCI Insight. 2018;3: pubmed 出版商
  98. Fujisaka Y, Iwata T, Tamai K, Nakamura M, Mochizuki M, Shibuya R, et al. Long non-coding RNA HOTAIR up-regulates chemokine (C-C motif) ligand 2 and promotes proliferation of macrophages and myeloid-derived suppressor cells in hepatocellular carcinoma cell lines. Oncol Lett. 2018;15:509-514 pubmed 出版商
  99. Bujko A, Atlasy N, Landsverk O, Richter L, Yaqub S, Horneland R, et al. Transcriptional and functional profiling defines human small intestinal macrophage subsets. J Exp Med. 2018;215:441-458 pubmed 出版商
  100. Kyoizumi S, Kubo Y, Kajimura J, Yoshida K, Hayashi T, Nakachi K, et al. Fate Decision Between Group 3 Innate Lymphoid and Conventional NK Cell Lineages by Notch Signaling in Human Circulating Hematopoietic Progenitors. J Immunol. 2017;199:2777-2793 pubmed 出版商
  101. Vitallé J, Zenarruzabeitia O, Terrén I, Plana M, Guardo A, Leal L, et al. Monocytes Phenotype and Cytokine Production in Human Immunodeficiency Virus-1 Infected Patients Receiving a Modified Vaccinia Ankara-Based HIV-1 Vaccine: Relationship to CD300 Molecules Expression. Front Immunol. 2017;8:836 pubmed 出版商
  102. Zhang X, Lian X, Dai Z, Zheng H, Chen X, Zheng Y. ?3-Deletion Isoform of HLA-A11 Modulates Cytotoxicity of NK Cells: Correlations with HIV-1 Infection of Cells. J Immunol. 2017;199:2030-2042 pubmed 出版商
  103. Resheq Y, Menzner A, Bosch J, Tickle J, Li K, Wilhelm A, et al. Impaired Transmigration of Myeloid-Derived Suppressor Cells across Human Sinusoidal Endothelium Is Associated with Decreased Expression of CD13. J Immunol. 2017;199:1672-1681 pubmed 出版商
  104. Gorvel L, Korenfeld D, Tung T, Klechevsky E. Dendritic Cell-Derived IL-32?: A Novel Inhibitory Cytokine of NK Cell Function. J Immunol. 2017;199:1290-1300 pubmed 出版商
  105. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed 出版商
  106. Shah F, Stepan A, O Mahony A, Velichko S, Folias A, Houle C, et al. Mechanisms of Skin Toxicity Associated with Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators. Cell Chem Biol. 2017;24:858-869.e5 pubmed 出版商
  107. Allan D, Cerdeira A, Ranjan A, Kirkham C, Aguilar O, Tanaka M, et al. Transcriptome analysis reveals similarities between human blood CD3- CD56bright cells and mouse CD127+ innate lymphoid cells. Sci Rep. 2017;7:3501 pubmed 出版商
  108. Gosselin D, Skola D, Coufal N, Holtman I, Schlachetzki J, Sajti E, et al. An environment-dependent transcriptional network specifies human microglia identity. Science. 2017;356: pubmed 出版商
  109. Yamashita Y, Anczurowski M, Nakatsugawa M, Tanaka M, Kagoya Y, Sinha A, et al. HLA-DP84Gly constitutively presents endogenous peptides generated by the class I antigen processing pathway. Nat Commun. 2017;8:15244 pubmed 出版商
  110. Cerboni S, Jeremiah N, Gentili M, Gehrmann U, Conrad C, Stolzenberg M, et al. Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes. J Exp Med. 2017;214:1769-1785 pubmed 出版商
  111. Chevrier S, Levine J, Zanotelli V, Silina K, Schulz D, Bacac M, et al. An Immune Atlas of Clear Cell Renal Cell Carcinoma. Cell. 2017;169:736-749.e18 pubmed 出版商
  112. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed 出版商
  113. Pryke K, Abraham J, Sali T, Gall B, Archer I, Liu A, et al. A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses. MBio. 2017;8: pubmed 出版商
  114. Villani A, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356: pubmed 出版商
  115. Zhang J, Xu X, Shi M, Chen Y, Yu D, Zhao C, et al. CD13hi Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancreatic ductal adenocarcinoma. Oncoimmunology. 2017;6:e1258504 pubmed 出版商
  116. Mytych J, Romerowicz Misielak M, Koziorowski M. Long-term culture with lipopolysaccharide induces dose-dependent cytostatic and cytotoxic effects in THP-1 monocytes. Toxicol In Vitro. 2017;42:1-9 pubmed 出版商
  117. Tyler C, McCarthy N, Lindsay J, Stagg A, Moser B, Eberl M. Antigen-Presenting Human γδ T Cells Promote Intestinal CD4+ T Cell Expression of IL-22 and Mucosal Release of Calprotectin. J Immunol. 2017;198:3417-3425 pubmed 出版商
  118. Descours B, Petitjean G, López Zaragoza J, Bruel T, Raffel R, Psomas C, et al. CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses. Nature. 2017;543:564-567 pubmed 出版商
  119. Li R, Rezk A, Li H, Gommerman J, Prat A, Bar Or A. Antibody-Independent Function of Human B Cells Contributes to Antifungal T Cell Responses. J Immunol. 2017;198:3245-3254 pubmed 出版商
  120. Botting R, Bertram K, Baharlou H, Sandgren K, Fletcher J, Rhodes J, et al. Phenotypic and functional consequences of different isolation protocols on skin mononuclear phagocytes. J Leukoc Biol. 2017;101:1393-1403 pubmed 出版商
  121. Cardinaud S, Urrutia A, Rouers A, Coulon P, Kervevan J, Richetta C, et al. Triggering of TLR-3, -4, NOD2, and DC-SIGN reduces viral replication and increases T-cell activation capacity of HIV-infected human dendritic cells. Eur J Immunol. 2017;47:818-829 pubmed 出版商
  122. Kumar D, Puan K, Andiappan A, Lee B, Westerlaken G, Haase D, et al. A functional SNP associated with atopic dermatitis controls cell type-specific methylation of the VSTM1 gene locus. Genome Med. 2017;9:18 pubmed 出版商
  123. Hartwig T, Montinaro A, von Karstedt S, Sevko A, Surinova S, Chakravarthy A, et al. The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2. Mol Cell. 2017;65:730-742.e5 pubmed 出版商
  124. Wouters K, Gaens K, Bijnen M, Verboven K, Jocken J, Wetzels S, et al. Circulating classical monocytes are associated with CD11c+ macrophages in human visceral adipose tissue. Sci Rep. 2017;7:42665 pubmed 出版商
  125. Su S, Zou Z, Chen F, Ding N, Du J, Shao J, et al. CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer. Oncoimmunology. 2017;6:e1249558 pubmed 出版商
  126. Smith N, Pietrancosta N, Davidson S, Dutrieux J, Chauveau L, Cutolo P, et al. Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement. Nat Commun. 2017;8:14253 pubmed 出版商
  127. O CONNOR D, Clutterbuck E, Thompson A, Snape M, Ramasamy M, Kelly D, et al. High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine. Genome Med. 2017;9:11 pubmed 出版商
  128. Salvatori G, Foligno S, Sirleto P, Genovese S, Russo S, Coletti V, et al. Sometimes it is better to wait: First Italian case of a newborn with transient abnormal myelopoiesis and a favorable prognosis. Oncol Lett. 2017;13:191-195 pubmed 出版商
  129. Raposo R, de Mulder Rougvie M, Paquin Proulx D, Brailey P, Cabido V, Zdinak P, et al. IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis. JCI Insight. 2017;2:e85811 pubmed 出版商
  130. Sontag S, Förster M, Qin J, Wanek P, Mitzka S, Schüler H, et al. Modelling IRF8 Deficient Human Hematopoiesis and Dendritic Cell Development with Engineered iPS Cells. Stem Cells. 2017;35:898-908 pubmed 出版商
  131. Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017;7:40354 pubmed 出版商
  132. Wonderlich E, Swan Z, Bissel S, Hartman A, Carney J, O Malley K, et al. Widespread Virus Replication in Alveoli Drives Acute Respiratory Distress Syndrome in Aerosolized H5N1 Influenza Infection of Macaques. J Immunol. 2017;198:1616-1626 pubmed 出版商
  133. Uruha A, Nishikawa A, Tsuburaya R, Hamanaka K, Kuwana M, Watanabe Y, et al. Sarcoplasmic MxA expression: A valuable marker of dermatomyositis. Neurology. 2017;88:493-500 pubmed 出版商
  134. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed 出版商
  135. Dross S, Munson P, Kim S, Bratt D, Tunggal H, Gervassi A, et al. Kinetics of Myeloid-Derived Suppressor Cell Frequency and Function during Simian Immunodeficiency Virus Infection, Combination Antiretroviral Therapy, and Treatment Interruption. J Immunol. 2017;198:757-766 pubmed 出版商
  136. Assadi G, Vesterlund L, Bonfiglio F, Mazzurana L, Cordeddu L, Schepis D, et al. Functional Analyses of the Crohn's Disease Risk Gene LACC1. PLoS ONE. 2016;11:e0168276 pubmed 出版商
  137. Das A, McDonald D, Lowe S, Bredlau A, Vanek K, Patel S, et al. Immunological low-dose radiation modulates the pediatric medulloblastoma antigens and enhances antibody-dependent cellular cytotoxicity. Childs Nerv Syst. 2017;33:429-436 pubmed 出版商
  138. Cheng L, Ma J, Li J, Li D, Li G, Li F, et al. Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs. J Clin Invest. 2017;127:269-279 pubmed 出版商
  139. Zhen A, Rezek V, Youn C, Lam B, Chang N, Rick J, et al. Targeting type I interferon-mediated activation restores immune function in chronic HIV infection. J Clin Invest. 2017;127:260-268 pubmed 出版商
  140. Kasturi S, Kozlowski P, Nakaya H, Burger M, Russo P, Pham M, et al. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques. J Virol. 2017;91: pubmed 出版商
  141. Faivre V, Lukaszewicz A, Payen D. Downregulation of Blood Monocyte HLA-DR in ICU Patients Is Also Present in Bone Marrow Cells. PLoS ONE. 2016;11:e0164489 pubmed 出版商
  142. Snyder Mackler N, Sanz J, Kohn J, Brinkworth J, Morrow S, Shaver A, et al. Social status alters immune regulation and response to infection in macaques. Science. 2016;354:1041-1045 pubmed
  143. Ju X, Silveira P, Hsu W, Elgundi Z, Alingcastre R, Verma N, et al. The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population. J Immunol. 2016;197:4613-4625 pubmed
  144. Gouwy M, Ruytinx P, Radice E, Claudi F, Van Raemdonck K, Bonecchi R, et al. CXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and Phagocytosis. PLoS ONE. 2016;11:e0166006 pubmed 出版商
  145. Soares A, Neves P, Cavalcanti M, Marinho S, Oliveira W, Souza J, et al. Expression of co-stimulatory molecules CD80 and CD86 is altered in CD14 + HLA-DR + monocytes from patients with Chagas disease following induction by Trypanosoma cruzi recombinant antigens. Rev Soc Bras Med Trop. 2016;49:632-636 pubmed 出版商
  146. Casamayor Genescà A, Pla A, Oliver Vila I, Pujals Fonts N, Marín Gallén S, Caminal M, et al. Clinical-scale expansion of CD34+ cord blood cells amplifies committed progenitors and rapid scid repopulation cells. N Biotechnol. 2017;35:19-29 pubmed 出版商
  147. Yao Y, Welp T, Liu Q, Niu N, Wang X, Britto C, et al. Multiparameter Single Cell Profiling of Airway Inflammatory Cells. Cytometry B Clin Cytom. 2017;92:12-20 pubmed 出版商
  148. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed 出版商
  149. van Haren S, Dowling D, Foppen W, Christensen D, Andersen P, Reed S, et al. Age-Specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1 Polarization. J Immunol. 2016;197:4413-4424 pubmed
  150. Dyer W, Tan J, Day T, Kiers L, Kiernan M, Yiannikas C, et al. Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy. Brain Behav. 2016;6:e00516 pubmed
  151. Yu Z, Zou Y, Fan J, Li C, Ma L. Notch1 is associated with the differentiation of human bone marrow?derived mesenchymal stem cells to cardiomyocytes. Mol Med Rep. 2016;14:5065-5071 pubmed 出版商
  152. Nagase H, Takeoka T, Urakawa S, Morimoto Okazawa A, Kawashima A, Iwahori K, et al. ICOS+ Foxp3+ TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori. Int J Cancer. 2017;140:686-695 pubmed 出版商
  153. Byrareddy S, Arthos J, Cicala C, Villinger F, Ortiz K, Little D, et al. Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy. Science. 2016;354:197-202 pubmed
  154. Misra S, Selvam A, Wallenberg M, Ambati A, Matolcsy A, Magalhaes I, et al. Selenite promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells. Oncotarget. 2016;7:74686-74700 pubmed 出版商
  155. Chandele A, Sewatanon J, Gunisetty S, Singla M, Onlamoon N, Akondy R, et al. Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India. J Virol. 2016;90:11259-11278 pubmed
  156. Oon S, Huynh H, Tai T, Ng M, Monaghan K, Biondo M, et al. A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus. JCI Insight. 2016;1:e86131 pubmed 出版商
  157. Komdeur F, Wouters M, Workel H, Tijans A, Terwindt A, Brunekreeft K, et al. CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy. Oncotarget. 2016;7:75130-75144 pubmed 出版商
  158. Wang Y, Ma C, Ling Y, Bousfiha A, Camcioglu Y, Jacquot S, et al. Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations. J Exp Med. 2016;213:2413-2435 pubmed
  159. Sugita S, Iwasaki Y, Makabe K, Kimura T, Futagami T, Suegami S, et al. Lack of T Cell Response to iPSC-Derived Retinal Pigment Epithelial Cells from HLA Homozygous Donors. Stem Cell Reports. 2016;7:619-634 pubmed 出版商
  160. Gaido C, Stone S, Chopra A, Thomas W, LE SOUEF P, Hales B. Immunodominant T-Cell Epitopes in the VP1 Capsid Protein of Rhinovirus Species A and C. J Virol. 2016;90:10459-10471 pubmed 出版商
  161. Foerster F, Bamberger D, Schupp J, Weilbächer M, Kaps L, Strobl S, et al. Dextran-based therapeutic nanoparticles for hepatic drug delivery. Nanomedicine (Lond). 2016;11:2663-2677 pubmed
  162. Di Blasio S, Wortel I, van Bladel D, de Vries L, Duiveman de Boer T, Worah K, et al. Human CD1c(+) DCs are critical cellular mediators of immune responses induced by immunogenic cell death. Oncoimmunology. 2016;5:e1192739 pubmed 出版商
  163. Kelly A, Robinson M, Roche G, Biron C, O Farrelly C, Ryan E. Immune Cell Profiling of IFN-? Response Shows pDCs Express Highest Level of IFN-?R1 and Are Directly Responsive via the JAK-STAT Pathway. J Interferon Cytokine Res. 2016;36:671-680 pubmed
  164. Keefer M, Zheng B, Rosenberg A, Kobie J. Increased Steady-State Memory B Cell Subsets Among High-Risk Participants in an HIV Vaccine Trial. AIDS Res Hum Retroviruses. 2016;32:1143-1148 pubmed
  165. Zahran A, Aly S, Altayeb H, Ali A. Circulating endothelial cells and their progenitors in acute myeloid leukemia. Oncol Lett. 2016;12:1965-1970 pubmed
  166. Zenarruzabeitia O, Vitallé J, Garcia Obregon S, Astigarraga I, Eguizabal C, Santos S, et al. The expression and function of human CD300 receptors on blood circulating mononuclear cells are distinct in neonates and adults. Sci Rep. 2016;6:32693 pubmed 出版商
  167. Beatson R, Tajadura Ortega V, Achkova D, Picco G, Tsourouktsoglou T, Klausing S, et al. The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9. Nat Immunol. 2016;17:1273-1281 pubmed 出版商
  168. Deng Y, Cheng J, Fu B, Liu W, Chen G, Zhang Q, et al. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells. Oncogene. 2017;36:1090-1101 pubmed 出版商
  169. Ilkovitch D, Ferris L. Myeloid-derived suppressor cells are elevated in patients with psoriasis and produce various molecules. Mol Med Rep. 2016;14:3935-40 pubmed 出版商
  170. Greco S, Torres Hernandez A, Kalabin A, Whiteman C, Rokosh R, Ravirala S, et al. Mincle Signaling Promotes Con A Hepatitis. J Immunol. 2016;197:2816-27 pubmed 出版商
  171. Rosskopf S, Jutz S, Neunkirchner A, Candia M, Jahn Schmid B, Bohle B, et al. Creation of an engineered APC system to explore and optimize the presentation of immunodominant peptides of major allergens. Sci Rep. 2016;6:31580 pubmed 出版商
  172. Loegl J, Hiden U, Nussbaumer E, Schliefsteiner C, Cvitic S, Lang I, et al. Hofbauer cells of M2a, M2b and M2c polarization may regulate feto-placental angiogenesis. Reproduction. 2016;152:447-55 pubmed 出版商
  173. van Erp F, Knol E, Pontoppidan B, Meijer Y, van der Ent C, Knulst A. The IgE and basophil responses to Ara h 2 and Ara h 6 are good predictors of peanut allergy in children. J Allergy Clin Immunol. 2017;139:358-360.e8 pubmed 出版商
  174. Camilleri E, Gustafson M, Dudakovic A, Riester S, Garces C, Paradise C, et al. Identification and validation of multiple cell surface markers of clinical-grade adipose-derived mesenchymal stromal cells as novel release criteria for good manufacturing practice-compliant production. Stem Cell Res Ther. 2016;7:107 pubmed 出版商
  175. Yao Y, Deng Q, Song W, Zhang H, Li Y, Yang Y, et al. MIF Plays a Key Role in Regulating Tissue-Specific Chondro-Osteogenic Differentiation Fate of Human Cartilage Endplate Stem Cells under Hypoxia. Stem Cell Reports. 2016;7:249-62 pubmed 出版商
  176. Xing Y, Cao R, Hu H. TLR and NLRP3 inflammasome-dependent innate immune responses to tumor-derived autophagosomes (DRibbles). Cell Death Dis. 2016;7:e2322 pubmed 出版商
  177. Manickam C, Rajakumar P, Wachtman L, Kramer J, Martinot A, Varner V, et al. Acute Liver Damage Associated with Innate Immune Activation in a Small Nonhuman Primate Model of Hepacivirus Infection. J Virol. 2016;90:9153-62 pubmed 出版商
  178. Demers K, Makedonas G, Buggert M, Eller M, Ratcliffe S, Goonetilleke N, et al. Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection. PLoS Pathog. 2016;12:e1005805 pubmed 出版商
  179. Cerny D, Thi Le D, The T, Zuest R, Kg S, Velumani S, et al. Complete human CD1a deficiency on Langerhans cells due to a rare point mutation in the coding sequence. J Allergy Clin Immunol. 2016;138:1709-1712.e11 pubmed 出版商
  180. Paquin Proulx D, Gibbs A, Bachle S, Checa A, Introini A, Leeansyah E, et al. Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion. J Immunol. 2016;197:1843-51 pubmed 出版商
  181. Rölle A, Halenius A, Ewen E, Cerwenka A, Hengel H, Momburg F. CD2-CD58 interactions are pivotal for the activation and function of adaptive natural killer cells in human cytomegalovirus infection. Eur J Immunol. 2016;46:2420-2425 pubmed 出版商
  182. Jacoby E, Nguyen S, Fountaine T, Welp K, Gryder B, Qin H, et al. CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity. Nat Commun. 2016;7:12320 pubmed 出版商
  183. Coccaro N, Tota G, Anelli L, Zagaria A, Casieri P, Cellamare A, et al. MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32). Oncol Lett. 2016;12:1460-1464 pubmed
  184. Pinilla Vera M, Xiong Z, Zhao Y, Zhao J, Donahoe M, Barge S, et al. Full Spectrum of LPS Activation in Alveolar Macrophages of Healthy Volunteers by Whole Transcriptomic Profiling. PLoS ONE. 2016;11:e0159329 pubmed 出版商
  185. Ding L, Hayes M, Photenhauer A, Eaton K, Li Q, Ocadiz Ruiz R, et al. Schlafen 4-expressing myeloid-derived suppressor cells are induced during murine gastric metaplasia. J Clin Invest. 2016;126:2867-80 pubmed 出版商
  186. Codinach M, Blanco M, Ortega I, Lloret M, Reales L, Coca M, et al. Design and validation of a consistent and reproducible manufacture process for the production of clinical-grade bone marrow-derived multipotent mesenchymal stromal cells. Cytotherapy. 2016;18:1197-208 pubmed 出版商
  187. Wittmann A, Lamprinaki D, Bowles K, Katzenellenbogen E, Knirel Y, Whitfield C, et al. Dectin-2 Recognizes Mannosylated O-antigens of Human Opportunistic Pathogens and Augments Lipopolysaccharide Activation of Myeloid Cells. J Biol Chem. 2016;291:17629-38 pubmed 出版商
  188. Cheng W, van Asten S, Burns L, Evans H, Walter G, Hashim A, et al. Periodontitis-associated pathogens P. gingivalis and A. actinomycetemcomitans activate human CD14(+) monocytes leading to enhanced Th17/IL-17 responses. Eur J Immunol. 2016;46:2211-21 pubmed 出版商
  189. Booth J, Duggan E, Patel V, Langer M, Wu W, Braun A, et al. Bacillus anthracis spore movement does not require a carrier cell and is not affected by lethal toxin in human lung models. Microbes Infect. 2016;18:615-626 pubmed 出版商
  190. Lo T, Silveira P, Fromm P, Verma N, Vu P, Kupresanin F, et al. Characterization of the Expression and Function of the C-Type Lectin Receptor CD302 in Mice and Humans Reveals a Role in Dendritic Cell Migration. J Immunol. 2016;197:885-98 pubmed 出版商
  191. Gadd V, Patel P, Jose S, Horsfall L, Powell E, Irvine K. Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation. PLoS ONE. 2016;11:e0157771 pubmed 出版商
  192. Domingues R, de Carvalho G, Aoki V, da Silva Duarte A, Sato M. Activation of myeloid dendritic cells, effector cells and regulatory T cells in lichen planus. J Transl Med. 2016;14:171 pubmed 出版商
  193. Zanetti S, Ziblat A, Torres N, Zwirner N, Bouzat C. Expression and Functional Role of ?7 Nicotinic Receptor in Human Cytokine-stimulated Natural Killer (NK) Cells. J Biol Chem. 2016;291:16541-52 pubmed 出版商
  194. Neumann B, Shi T, Gan L, Klippert A, Daskalaki M, Stolte Leeb N, et al. Comprehensive panel of cross-reacting monoclonal antibodies for analysis of different immune cells and their distribution in the common marmoset (Callithrix jacchus). J Med Primatol. 2016;45:139-46 pubmed 出版商
  195. Reinisch A, Thomas D, Corces M, Zhang X, Gratzinger D, Hong W, et al. A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells. Nat Med. 2016;22:812-21 pubmed 出版商
  196. Gren S, Janciauskiene S, Sandeep S, Jonigk D, Kvist P, Gerwien J, et al. The protease inhibitor cystatin C down-regulates the release of IL-? and TNF-? in lipopolysaccharide activated monocytes. J Leukoc Biol. 2016;100:811-822 pubmed
  197. Göbel K, Pankratz S, Asaridou C, Herrmann A, Bittner S, Merker M, et al. Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells. Nat Commun. 2016;7:11626 pubmed 出版商
  198. Welte T, Kim I, Tian L, Gao X, Wang H, Li J, et al. Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation. Nat Cell Biol. 2016;18:632-44 pubmed 出版商
  199. Rai V, Rao V, Shao Z, Agrawal D. Dendritic Cells Expressing Triggering Receptor Expressed on Myeloid Cells-1 Correlate with Plaque Stability in Symptomatic and Asymptomatic Patients with Carotid Stenosis. PLoS ONE. 2016;11:e0154802 pubmed 出版商
  200. Ruibal P, Oestereich L, Lüdtke A, Becker Ziaja B, Wozniak D, Kerber R, et al. Unique human immune signature of Ebola virus disease in Guinea. Nature. 2016;533:100-4 pubmed 出版商
  201. Hollmen M, Karaman S, Schwager S, Lisibach A, Christiansen A, Maksimow M, et al. G-CSF regulates macrophage phenotype and associates with poor overall survival in human triple-negative breast cancer. Oncoimmunology. 2016;5:e1115177 pubmed
  202. Cook A, McDonnell A, Lake R, Nowak A. Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies. Oncoimmunology. 2016;5:e1066062 pubmed
  203. Qualai J, Li L, Cantero J, Tarrats A, Fernández M, Sumoy L, et al. Expression of CD11c Is Associated with Unconventional Activated T Cell Subsets with High Migratory Potential. PLoS ONE. 2016;11:e0154253 pubmed 出版商
  204. Shen C, Detry B, Lecocq M, Pilette C. A novel IgA/Delta-like 4/Notch axis induces immunosuppressive activity in human dendritic cells. Clin Immunol. 2016;168:37-46 pubmed 出版商
  205. Li H, Borrego F, Nagata S, Tolnay M. Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells. J Immunol. 2016;196:4064-74 pubmed 出版商
  206. Zwang N, Zhang R, Germana S, Fan M, Hastings W, Cao A, et al. Selective Sparing of Human Tregs by Pharmacologic Inhibitors of the Phosphatidylinositol 3-Kinase and MEK Pathways. Am J Transplant. 2016;16:2624-38 pubmed 出版商
  207. Leone D, Kozakowski N, Kornauth C, Waidacher T, Neudert B, Loeffler A, et al. The Phenotypic Characterization of the Human Renal Mononuclear Phagocytes Reveal a Co-Ordinated Response to Injury. PLoS ONE. 2016;11:e0151674 pubmed 出版商
  208. Moreira M, Costa Pereira C, Alves M, Marteleto B, Ribeiro V, Peruhype Magalhães V, et al. Vaccination against canine leishmaniosis increases the phagocytic activity, nitric oxide production and expression of cell activation/migration molecules in neutrophils and monocytes. Vet Parasitol. 2016;220:33-45 pubmed 出版商
  209. Chung S, Rho S, Kim G, Kim S, Baek K, Kang M, et al. Human umbilical cord blood mononuclear cells and chorionic plate-derived mesenchymal stem cells promote axon survival in a rat model of optic nerve crush injury. Int J Mol Med. 2016;37:1170-80 pubmed 出版商
  210. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  211. Gao J, Duan Z, Zhang L, Huang X, Long L, Tu J, et al. Failure recovery of circulating NKG2D+CD56dimNK cells in HBV-associated hepatocellular carcinoma after hepatectomy predicts early recurrence. Oncoimmunology. 2016;5:e1048061 pubmed
  212. Leitch C, Natafji E, Yu C, Abdul Ghaffar S, Madarasingha N, Venables Z, et al. Filaggrin-null mutations are associated with increased maturation markers on Langerhans cells. J Allergy Clin Immunol. 2016;138:482-490.e7 pubmed 出版商
  213. Mosquera Restrepo S, Caro A, Peláez Jaramillo C, Rojas M. Mononuclear phagocyte accumulates a stearic acid derivative during differentiation into macrophages. Effects of stearic acid on macrophage differentiation and Mycobacterium tuberculosis control. Cell Immunol. 2016;303:24-33 pubmed 出版商
  214. Zondler L, Müller K, Khalaji S, Bliederhäuser C, Ruf W, Grozdanov V, et al. Peripheral monocytes are functionally altered and invade the CNS in ALS patients. Acta Neuropathol. 2016;132:391-411 pubmed 出版商
  215. Hogan L, Jones D, Allen R. Expression of the innate immune receptor LILRB5 on monocytes is associated with mycobacteria exposure. Sci Rep. 2016;6:21780 pubmed 出版商
  216. Phuah J, Wong E, Gideon H, Maiello P, Coleman M, Hendricks M, et al. Effects of B Cell Depletion on Early Mycobacterium tuberculosis Infection in Cynomolgus Macaques. Infect Immun. 2016;84:1301-1311 pubmed 出版商
  217. Srivastava P, Paluch B, Matsuzaki J, James S, Collamat Lai G, Blagitko Dorfs N, et al. Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy. Oncotarget. 2016;7:12840-56 pubmed 出版商
  218. Gupta S, Termini J, Issac B, Guirado E, Stone G. Constitutively Active MAVS Inhibits HIV-1 Replication via Type I Interferon Secretion and Induction of HIV-1 Restriction Factors. PLoS ONE. 2016;11:e0148929 pubmed 出版商
  219. Veazey R, Pilch Cooper H, Hope T, Alter G, Carias A, Sips M, et al. Prevention of SHIV transmission by topical IFN-β treatment. Mucosal Immunol. 2016;9:1528-1536 pubmed 出版商
  220. Johnson D, Estrada M, Salgado R, Sanchez V, Doxie D, Opalenik S, et al. Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy. Nat Commun. 2016;7:10582 pubmed 出版商
  221. Su S, Hu B, Shao J, Shen B, Du J, Du Y, et al. CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients. Sci Rep. 2016;6:20070 pubmed 出版商
  222. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed 出版商
  223. Rebbapragada I, Birkus G, Perry J, Xing W, Kwon H, Pflanz S. Molecular Determinants of GS-9620-Dependent TLR7 Activation. PLoS ONE. 2016;11:e0146835 pubmed 出版商
  224. Waschbisch A, Schröder S, Schraudner D, Sammet L, Weksler B, Melms A, et al. Pivotal Role for CD16+ Monocytes in Immune Surveillance of the Central Nervous System. J Immunol. 2016;196:1558-67 pubmed 出版商
  225. Younis R, Han K, Webb T. Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells. J Immunol. 2016;196:1419-29 pubmed 出版商
  226. Gonzalez S, Taborda N, Correa L, Castro G, Hernandez J, Montoya C, et al. Particular activation phenotype of T cells expressing HLA-DR but not CD38 in GALT from HIV-controllers is associated with immune regulation and delayed progression to AIDS. Immunol Res. 2016;64:765-74 pubmed 出版商
  227. Wang H, Feng F, Wang X, Wang R, Wu Y, Zhu M, et al. Dendritic cells pulsed with Hsp70 and HBxAg induce specific antitumor immune responses in hepatitis B virus-associated hepatocellular carcinoma. Mol Med Rep. 2016;13:1077-82 pubmed 出版商
  228. Laner Plamberger S, Lener T, Schmid D, Streif D, Salzer T, Öller M, et al. Mechanical fibrinogen-depletion supports heparin-free mesenchymal stem cell propagation in human platelet lysate. J Transl Med. 2015;13:354 pubmed 出版商
  229. Javed A, Leuchte N, Neumann B, Sopper S, Sauermann U. Noncytolytic CD8+ Cell Mediated Antiviral Response Represents a Strong Element in the Immune Response of Simian Immunodeficiency Virus-Infected Long-Term Non-Progressing Rhesus Macaques. PLoS ONE. 2015;10:e0142086 pubmed 出版商
  230. Oliver Vila I, Coca M, Grau Vorster M, Pujals Fonts N, Caminal M, Casamayor Genescà A, et al. Evaluation of a cell-banking strategy for the production of clinical grade mesenchymal stromal cells from Wharton's jelly. Cytotherapy. 2016;18:25-35 pubmed 出版商
  231. Vierboom M, Breedveld E, Kap Y, Mary C, Poirier N, t Hart B, et al. Clinical efficacy of a new CD28-targeting antagonist of T cell co-stimulation in a non-human primate model of collagen-induced arthritis. Clin Exp Immunol. 2016;183:405-18 pubmed 出版商
  232. Brown P, Wong K, Felce S, Lyne L, Spearman H, Soilleux E, et al. FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas. Leukemia. 2016;30:605-16 pubmed 出版商
  233. Li R, Rezk A, Miyazaki Y, Hilgenberg E, Touil H, Shen P, et al. Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy. Sci Transl Med. 2015;7:310ra166 pubmed 出版商
  234. Miles B, Miller S, Folkvord J, Kimball A, Chamanian M, Meditz A, et al. Follicular regulatory T cells impair follicular T helper cells in HIV and SIV infection. Nat Commun. 2015;6:8608 pubmed 出版商
  235. Venkatasubramanian S, Tripathi D, Tucker T, Paidipally P, Cheekatla S, Welch E, et al. Tissue factor expression by myeloid cells contributes to protective immune response against Mycobacterium tuberculosis infection. Eur J Immunol. 2016;46:464-79 pubmed 出版商
  236. Byrareddy S, Little D, Mayne A, Villinger F, Ansari A. Phenotypic and Functional Characterization of Monoclonal Antibodies with Specificity for Rhesus Macaque CD200, CD200R and Mincle. PLoS ONE. 2015;10:e0140689 pubmed 出版商
  237. Schulz A, Mälzer J, Domingo C, Jürchott K, Grützkau A, Babel N, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195:4699-711 pubmed 出版商
  238. Okoye Okafor U, Bartholdy B, Cartier J, Gao E, Pietrak B, Rendina A, et al. New IDH1 mutant inhibitors for treatment of acute myeloid leukemia. Nat Chem Biol. 2015;11:878-86 pubmed 出版商
  239. Mitson Salazar A, Yin Y, Wansley D, Young M, Bolan H, Arceo S, et al. Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T(H)2 cell subpopulation with enhanced function. J Allergy Clin Immunol. 2016;137:907-18.e9 pubmed 出版商
  240. McCausland M, Juchnowski S, Zidar D, Kuritzkes D, Andrade A, Sieg S, et al. Altered Monocyte Phenotype in HIV-1 Infection Tends to Normalize with Integrase-Inhibitor-Based Antiretroviral Therapy. PLoS ONE. 2015;10:e0139474 pubmed 出版商
  241. Rosario M, Liu B, Kong L, Collins L, Schneider S, Chen X, et al. The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas. Clin Cancer Res. 2016;22:596-608 pubmed 出版商
  242. Frederiksen J, Buggert M, Noyan K, Nowak P, Sönnerborg A, Lund O, et al. Multidimensional Clusters of CD4+ T Cell Dysfunction Are Primarily Associated with the CD4/CD8 Ratio in Chronic HIV Infection. PLoS ONE. 2015;10:e0137635 pubmed 出版商
  243. Denkovskij J, Rudys R, Bernotiene E, Minderis M, Bagdonas S, Kirdaite G. Cell surface markers and exogenously induced PpIX in synovial mesenchymal stem cells. Cytometry A. 2015;87:1001-11 pubmed 出版商
  244. Gómez M, Qin Q, Biancardi M, Galiguis J, Dumas C, MacLean R, et al. Characterization and Multilineage Differentiation of Domestic and Black-Footed Cat Mesenchymal Stromal/Stem Cells from Abdominal and Subcutaneous Adipose Tissue. Cell Reprogram. 2015;17:376-92 pubmed 出版商
  245. Monteiro Carvalho Mori da Cunha M, Zia S, Oliveira Arcolino F, Carlon M, Beckmann D, Pippi N, et al. Amniotic Fluid Derived Stem Cells with a Renal Progenitor Phenotype Inhibit Interstitial Fibrosis in Renal Ischemia and Reperfusion Injury in Rats. PLoS ONE. 2015;10:e0136145 pubmed 出版商
  246. Leeansyah E, Svärd J, Dias J, Buggert M, Nyström J, Quigley M, et al. Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection. PLoS Pathog. 2015;11:e1005072 pubmed 出版商
  247. Kang R, Zhou Y, Tan S, Zhou G, Aagaard L, Xie L, et al. Mesenchymal stem cells derived from human induced pluripotent stem cells retain adequate osteogenicity and chondrogenicity but less adipogenicity. Stem Cell Res Ther. 2015;6:144 pubmed 出版商
  248. Dunham J, Lee L, van Driel N, Laman J, Ni I, Zhai W, et al. Blockade of CD127 Exerts a Dichotomous Clinical Effect in Marmoset Experimental Autoimmune Encephalomyelitis. J Neuroimmune Pharmacol. 2016;11:73-83 pubmed 出版商
  249. Li X, Liu X, Zhao Y, Zhong R, Song A, Sun L. Effect of thymosin α₁ on the phenotypic and functional maturation of dendritic cells from children with acute lymphoblastic leukemia. Mol Med Rep. 2015;12:6093-7 pubmed 出版商
  250. Ducret M, Fabre H, Farges J, Degoul O, Atzeni G, McGuckin C, et al. Production of Human Dental Pulp Cells with a Medicinal Manufacturing Approach. J Endod. 2015;41:1492-9 pubmed 出版商
  251. Bian Y, Qian W, Li H, Zhao R, Shan W, Weng X. Pathogenesis of glucocorticoid-induced avascular necrosis: A microarray analysis of gene expression in vitro. Int J Mol Med. 2015;36:678-84 pubmed 出版商
  252. Pojero F, Flores Montero J, Sanoja L, Pérez J, Puig N, Paiva B, et al. Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases. Cytometry B Clin Cytom. 2016;90:91-100 pubmed 出版商
  253. Yawata N, Selva K, Liu Y, Tan K, Lee A, Siak J, et al. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. Mucosal Immunol. 2016;9:159-70 pubmed 出版商
  254. Kasper J, Hermanns M, Unger R, Kirkpatrick C. A responsive human triple-culture model of the air-blood barrier: incorporation of different macrophage phenotypes. J Tissue Eng Regen Med. 2017;11:1285-1297 pubmed 出版商
  255. Maass P, Aydin A, Luft F, Schächterle C, Weise A, Stricker S, et al. PDE3A mutations cause autosomal dominant hypertension with brachydactyly. Nat Genet. 2015;47:647-53 pubmed 出版商
  256. Fromm J, Tagliente D, Shaver A, Neppalli V, Craig F. Case study interpretation: Report from the ICCS Annual Meeting, Seattle, 2014. Cytometry B Clin Cytom. 2015;88:413-24 pubmed 出版商
  257. Thomas K, Valenzuela N, Gjertson D, Mulder A, Fishbein M, Parry G, et al. An Anti-C1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLA. Am J Transplant. 2015;15:2037-49 pubmed 出版商
  258. Gardner J, Mamotte C, Patel P, Yeoh T, Jackaman C, Nelson D. Mesothelioma tumor cells modulate dendritic cell lipid content, phenotype and function. PLoS ONE. 2015;10:e0123563 pubmed 出版商
  259. Metcalf Pate K, Pohlmeyer C, Walker Sperling V, Foote J, Najarro K, Cryer C, et al. A Murine Viral Outgrowth Assay to Detect Residual HIV Type 1 in Patients With Undetectable Viral Loads. J Infect Dis. 2015;212:1387-96 pubmed 出版商
  260. Weinberg A, Muresan P, Richardson K, Fenton T, Domínguez T, Bloom A, et al. Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine. PLoS ONE. 2015;10:e0122431 pubmed 出版商
  261. Martner A, Wiktorin H, Lenox B, Ewald Sander F, Aydin E, Aurelius J, et al. Histamine promotes the development of monocyte-derived dendritic cells and reduces tumor growth by targeting the myeloid NADPH oxidase. J Immunol. 2015;194:5014-21 pubmed 出版商
  262. Koning N, Kessen S, van der Voorn J, Appelmelk B, Jeurink P, Knippels L, et al. Human Milk Blocks DC-SIGN-Pathogen Interaction via MUC1. Front Immunol. 2015;6:112 pubmed 出版商
  263. Yukl S, Shergill A, Girling V, Li Q, Killian M, Epling L, et al. Site-specific differences in T cell frequencies and phenotypes in the blood and gut of HIV-uninfected and ART-treated HIV+ adults. PLoS ONE. 2015;10:e0121290 pubmed 出版商
  264. Hong M, Sandalova E, Low D, Gehring A, Fieni S, Amadei B, et al. Trained immunity in newborn infants of HBV-infected mothers. Nat Commun. 2015;6:6588 pubmed 出版商
  265. Skogberg G, Lundberg V, Berglund M, Gudmundsdottir J, Telemo E, Lindgren S, et al. Human thymic epithelial primary cells produce exosomes carrying tissue-restricted antigens. Immunol Cell Biol. 2015;93:727-34 pubmed 出版商
  266. Dudek Perić A, Ferreira G, Muchowicz A, Wouters J, Prada N, Martin S, et al. Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulin. Cancer Res. 2015;75:1603-14 pubmed 出版商
  267. Claiborne D, Prince J, Scully E, Macharia G, Micci L, Lawson B, et al. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression. Proc Natl Acad Sci U S A. 2015;112:E1480-9 pubmed 出版商
  268. Lee J, Breton G, Oliveira T, Zhou Y, Aljoufi A, PUHR S, et al. Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow. J Exp Med. 2015;212:385-99 pubmed 出版商
  269. Bang M, Seo J, Seo J, Jo G, Jung S, Yu R, et al. Bacillus subtilis KCTC 11782BP-produced alginate oligosaccharide effectively suppresses asthma via T-helper cell type 2-related cytokines. PLoS ONE. 2015;10:e0117524 pubmed 出版商
  270. Rissiek A, Baumann I, Cuapio A, Mautner A, Kolster M, Arck P, et al. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation. J Autoimmun. 2015;58:12-20 pubmed 出版商
  271. Herbst S, Shah A, Mazon Moya M, Marzola V, Jensen B, Reed A, et al. Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus. EMBO Mol Med. 2015;7:240-58 pubmed 出版商
  272. Tomimaru Y, Mishra S, Safran H, Charpentier K, Martin W, De Groot A, et al. Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma. Vaccine. 2015;33:1256-66 pubmed 出版商
  273. Dimova T, Brouwer M, Gosselin F, Tassignon J, Leo O, Donner C, et al. Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire. Proc Natl Acad Sci U S A. 2015;112:E556-65 pubmed 出版商
  274. Abdel Mohsen M, Wang C, Strain M, Lada S, Deng X, Cockerham L, et al. Select host restriction factors are associated with HIV persistence during antiretroviral therapy. AIDS. 2015;29:411-20 pubmed 出版商
  275. Johnson P, Challis R, Chowdhury F, Gao Y, Harvey M, Geldart T, et al. Clinical and biological effects of an agonist anti-CD40 antibody: a Cancer Research UK phase I study. Clin Cancer Res. 2015;21:1321-8 pubmed 出版商
  276. Afshar M, Richards S, Mann D, Cross A, Smith G, Netzer G, et al. Acute immunomodulatory effects of binge alcohol ingestion. Alcohol. 2015;49:57-64 pubmed 出版商
  277. Fytianos K, Rodríguez Lorenzo L, Clift M, Blank F, Vanhecke D, von Garnier C, et al. Uptake efficiency of surface modified gold nanoparticles does not correlate with functional changes and cytokine secretion in human dendritic cells in vitro. Nanomedicine. 2015;11:633-44 pubmed 出版商
  278. Martin S, Dudek Perić A, Maes H, Garg A, Gabrysiak M, Demirsoy S, et al. Concurrent MEK and autophagy inhibition is required to restore cell death associated danger-signalling in Vemurafenib-resistant melanoma cells. Biochem Pharmacol. 2015;93:290-304 pubmed 出版商
  279. Heninger A, Wentrup S, Al Saeedi M, Schiessling S, Giese T, Wartha F, et al. Immunomodulation of human intestinal T cells by the synthetic CD80 antagonist RhuDex®. Immun Inflamm Dis. 2014;2:166-80 pubmed 出版商
  280. Campbell J, Ratai E, Autissier P, Nolan D, Tse S, Miller A, et al. Anti-?4 antibody treatment blocks virus traffic to the brain and gut early, and stabilizes CNS injury late in infection. PLoS Pathog. 2014;10:e1004533 pubmed 出版商
  281. Li H, Evans T, Gillis J, Connole M, Reeves R. Bone marrow-imprinted gut-homing of plasmacytoid dendritic cells (pDCs) in acute simian immunodeficiency virus infection results in massive accumulation of hyperfunctional CD4+ pDCs in the mucosae. J Infect Dis. 2015;211:1717-25 pubmed 出版商
  282. Vadasz S, JENSEN T, Moncada C, Girard E, Zhang F, Blanchette A, et al. Second and third trimester amniotic fluid mesenchymal stem cells can repopulate a de-cellularized lung scaffold and express lung markers. J Pediatr Surg. 2014;49:1554-63 pubmed 出版商
  283. Frontera Acevedo K, Sakamoto K. Local pulmonary immune responses in domestic cats naturally infected with Cytauxzoon felis. Vet Immunol Immunopathol. 2015;163:1-7 pubmed 出版商
  284. Van Eyck L, Hershfield M, Pombal D, Kelly S, Ganson N, Moens L, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol. 2015;135:283-7.e5 pubmed 出版商
  285. Cousens L, Najafian N, Martin W, De Groot A. Tregitope: Immunomodulation powerhouse. Hum Immunol. 2014;75:1139-46 pubmed 出版商
  286. Wang H, Zhang L, Zhang S, Li Y. Inhibition of vascular endothelial growth factor by small interfering RNA upregulates differentiation, maturation and function of dendritic cells. Exp Ther Med. 2015;9:120-124 pubmed
  287. Rueda C, Wells C, Gisslen T, Jobe A, Kallapur S, Chougnet C. Effect of chorioamnionitis on regulatory T cells in moderate/late preterm neonates. Hum Immunol. 2015;76:65-73 pubmed 出版商
  288. Hautefort A, Girerd B, Montani D, Cohen Kaminsky S, Price L, Lambrecht B, et al. T-helper 17 cell polarization in pulmonary arterial hypertension. Chest. 2015;147:1610-1620 pubmed 出版商
  289. Vogelpoel L, Hansen I, Rispens T, Muller F, van Capel T, Turina M, et al. Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages. Nat Commun. 2014;5:5444 pubmed 出版商
  290. Thompson I, Mann E, Stokes M, English N, Knight S, Williamson D. Specific activation of dendritic cells enhances clearance of Bacillus anthracis following infection. PLoS ONE. 2014;9:e109720 pubmed 出版商
  291. Milne P, Bigley V, Gunawan M, Haniffa M, Collin M. CD1c+ blood dendritic cells have Langerhans cell potential. Blood. 2015;125:470-3 pubmed 出版商
  292. Fernandez C, Amarasena T, Kelleher A, Rossjohn J, McCluskey J, Godfrey D, et al. MAIT cells are depleted early but retain functional cytokine expression in HIV infection. Immunol Cell Biol. 2015;93:177-88 pubmed 出版商
  293. Woodham A, Raff A, Da Silva D, Kast W. Molecular analysis of human papillomavirus virus-like particle activated Langerhans cells in vitro. Methods Mol Biol. 2015;1249:135-49 pubmed 出版商
  294. Freeman A, Bridge J, Maruthayanar P, Overgaard N, Jung J, Simpson F, et al. Comparative immune phenotypic analysis of cutaneous Squamous Cell Carcinoma and Intraepidermal Carcinoma in immune-competent individuals: proportional representation of CD8+ T-cells but not FoxP3+ Regulatory T-cells is associated with disease stage. PLoS ONE. 2014;9:e110928 pubmed 出版商
  295. Liao S, Ding T, Rao X, Sun D, Sun P, Wang Y, et al. Cigarette smoke affects dendritic cell maturation in the small airways of patients with chronic obstructive pulmonary disease. Mol Med Rep. 2015;11:219-25 pubmed 出版商
  296. Weed D, Vella J, Reis I, De La Fuente A, Gomez C, Sargi Z, et al. Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma. Clin Cancer Res. 2015;21:39-48 pubmed 出版商
  297. Rogacev K, Zawada A, Hundsdorfer J, Achenbach M, Held G, Fliser D, et al. Immunosuppression and monocyte subsets. Nephrol Dial Transplant. 2015;30:143-53 pubmed 出版商
  298. Ziblat A, Domaica C, Spallanzani R, Iraolagoitia X, Rossi L, Avila D, et al. IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness. Eur J Immunol. 2015;45:192-202 pubmed 出版商
  299. Maney N, Reynolds G, Krippner Heidenreich A, Hilkens C. Dendritic cell maturation and survival are differentially regulated by TNFR1 and TNFR2. J Immunol. 2014;193:4914-4923 pubmed 出版商
  300. O Regan N, Steinfelder S, Venugopal G, Rao G, Lucius R, Srikantam A, et al. Brugia malayi microfilariae induce a regulatory monocyte/macrophage phenotype that suppresses innate and adaptive immune responses. PLoS Negl Trop Dis. 2014;8:e3206 pubmed 出版商
  301. Yu C, Becker C, Metang P, Marches F, Wang Y, Toshiyuki H, et al. Human CD141+ dendritic cells induce CD4+ T cells to produce type 2 cytokines. J Immunol. 2014;193:4335-43 pubmed 出版商
  302. Yu J, Zuo Z, Zhang W, Yang Q, Zhang Y, Tang Y, et al. Identification of immunophenotypic subtypes with different prognoses in extranodal natural killer/T-cell lymphoma, nasal type. Hum Pathol. 2014;45:2255-62 pubmed 出版商
  303. Pritchard A, White O, Burel J, Carroll M, Phipps S, Upham J. Asthma is associated with multiple alterations in anti-viral innate signalling pathways. PLoS ONE. 2014;9:e106501 pubmed 出版商
  304. Li Z, Li W, Li N, Jiao Y, Chen D, Cui L, et al. γδ T cells are involved in acute HIV infection and associated with AIDS progression. PLoS ONE. 2014;9:e106064 pubmed 出版商
  305. Chao Y, Kaliaperumal N, Chretien A, Tang S, Lee B, Poidinger M, et al. Human plasmacytoid dendritic cells regulate IFN-α production through activation-induced splicing of IL-18Rα. J Leukoc Biol. 2014;96:1037-46 pubmed 出版商
  306. Davey M, Morgan M, Liuzzi A, Tyler C, Khan M, Szakmany T, et al. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol. 2014;193:3704-3716 pubmed 出版商
  307. Agrawal R, Wisniewski J, Yu M, Kennedy J, Platts Mills T, Heymann P, et al. Infection with human rhinovirus 16 promotes enhanced IgE responsiveness in basophils of atopic asthmatics. Clin Exp Allergy. 2014;44:1266-73 pubmed 出版商
  308. Li G, Cheng M, Nunoya J, Cheng L, Guo H, Yu H, et al. Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice. PLoS Pathog. 2014;10:e1004291 pubmed 出版商
  309. McNally A, Anderson J. Phenotypic expression in human monocyte-derived interleukin-4-induced foreign body giant cells and macrophages in vitro: dependence on material surface properties. J Biomed Mater Res A. 2015;103:1380-90 pubmed 出版商
  310. Lee Chang C, Bodogai M, Moritoh K, Olkhanud P, Chan A, Croft M, et al. Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity. Blood. 2014;124:1450-9 pubmed 出版商
  311. Buggert M, Tauriainen J, Yamamoto T, Frederiksen J, Ivarsson M, Michaelsson J, et al. T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection. PLoS Pathog. 2014;10:e1004251 pubmed 出版商
  312. Ramirez A, van der Flier W, Herold C, Ramonet D, Heilmann S, Lewczuk P, et al. SUCLG2 identified as both a determinator of CSF A?1-42 levels and an attenuator of cognitive decline in Alzheimer's disease. Hum Mol Genet. 2014;23:6644-58 pubmed 出版商
  313. Luteijn R, Hoelen H, Kruse E, van Leeuwen W, Grootens J, Horst D, et al. Cowpox virus protein CPXV012 eludes CTLs by blocking ATP binding to TAP. J Immunol. 2014;193:1578-89 pubmed 出版商
  314. Longman R, Diehl G, Victorio D, Huh J, Galan C, Miraldi E, et al. CX?CR1? mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J Exp Med. 2014;211:1571-83 pubmed 出版商
  315. Balan S, Ollion V, Colletti N, Chelbi R, Montanana Sanchis F, Liu H, et al. Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cells. J Immunol. 2014;193:1622-35 pubmed 出版商
  316. Jacquelin B, Petitjean G, Kunkel D, Liovat A, Jochems S, Rogers K, et al. Innate immune responses and rapid control of inflammation in African green monkeys treated or not with interferon-alpha during primary SIVagm infection. PLoS Pathog. 2014;10:e1004241 pubmed 出版商
  317. Ye S, Li Z, Luo D, Huang B, Chen Y, Zhang X, et al. Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma. Oncotarget. 2014;5:5439-52 pubmed
  318. Oksvold M, Kullmann A, Forfang L, Kierulf B, Li M, Brech A, et al. Expression of B-cell surface antigens in subpopulations of exosomes released from B-cell lymphoma cells. Clin Ther. 2014;36:847-862.e1 pubmed 出版商
  319. Zhang M, Ma Z, Selliah N, Weiss G, Genin A, Finkel T, et al. The impact of Nucleofection® on the activation state of primary human CD4 T cells. J Immunol Methods. 2014;408:123-31 pubmed 出版商
  320. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed 出版商
  321. Wilson E, Singh A, Hullsiek K, Gibson D, Henry W, Lichtenstein K, et al. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection. J Infect Dis. 2014;210:1396-406 pubmed 出版商
  322. Klinker M, Lizzio V, Reed T, Fox D, Lundy S. Human B Cell-Derived Lymphoblastoid Cell Lines Constitutively Produce Fas Ligand and Secrete MHCII(+)FasL(+) Killer Exosomes. Front Immunol. 2014;5:144 pubmed 出版商
  323. Mao C, Mou X, Zhou Y, Yuan G, Xu C, Liu H, et al. Tumor-activated TCR??? T cells from gastric cancer patients induce the antitumor immune response of TCR??? T cells via their antigen-presenting cell-like effects. J Immunol Res. 2014;2014:593562 pubmed 出版商
  324. Buggert M, Norstr m M, Salemi M, Hecht F, Karlsson A. Functional avidity and IL-2/perforin production is linked to the emergence of mutations within HLA-B*5701-restricted epitopes and HIV-1 disease progression. J Immunol. 2014;192:4685-96 pubmed 出版商
  325. Fredriksson K, Mishra A, Lam J, Mushaben E, Cuento R, Meyer K, et al. The very low density lipoprotein receptor attenuates house dust mite-induced airway inflammation by suppressing dendritic cell-mediated adaptive immune responses. J Immunol. 2014;192:4497-509 pubmed 出版商
  326. Shey M, Nemes E, Whatney W, de Kock M, Africa H, Barnard C, et al. Maturation of innate responses to mycobacteria over the first nine months of life. J Immunol. 2014;192:4833-43 pubmed 出版商
  327. Saulep Easton D, Vincent F, Le Page M, Wei A, Ting S, Croce C, et al. Cytokine-driven loss of plasmacytoid dendritic cell function in chronic lymphocytic leukemia. Leukemia. 2014;28:2005-15 pubmed 出版商
  328. Ito S, Bollard C, Carlsten M, Melenhorst J, Biancotto A, Wang E, et al. Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers. Mol Ther. 2014;22:1388-1395 pubmed 出版商
  329. Brittan M, Barr L, Anderson N, Morris A, Duffin R, Marwick J, et al. Functional characterisation of human pulmonary monocyte-like cells in lipopolysaccharide-mediated acute lung inflammation. J Inflamm (Lond). 2014;11:9 pubmed 出版商
  330. Abramowski P, Otto B, Martin R. The orally available, synthetic ether lipid edelfosine inhibits T cell proliferation and induces a type I interferon response. PLoS ONE. 2014;9:e91970 pubmed 出版商
  331. Hodara V, Parodi L, Chavez D, Smith L, Lanford R, Giavedoni L. Characterization of ??T cells in naïve and HIV-infected chimpanzees and their responses to T-cell activators in vitro. J Med Primatol. 2014;43:258-71 pubmed 出版商
  332. Lozano Fernández T, Ballester Antxordoki L, Pérez Temprano N, Rojas E, Sanz D, Iglesias Gaspar M, et al. Potential impact of metal oxide nanoparticles on the immune system: The role of integrins, L-selectin and the chemokine receptor CXCR4. Nanomedicine. 2014;10:1301-10 pubmed 出版商
  333. Søndergaard J, Vinner L, Brix S. Natural mannosylation of HIV-1 gp120 imposes no immunoregulatory effects in primary human plasmacytoid dendritic cells. Mol Immunol. 2014;59:180-7 pubmed 出版商
  334. Duggal N, Beswetherick A, Upton J, Hampson P, Phillips A, Lord J. Depressive symptoms in hip fracture patients are associated with reduced monocyte superoxide production. Exp Gerontol. 2014;54:27-34 pubmed 出版商
  335. Sereti I, Estes J, Thompson W, Morcock D, Fischl M, Croughs T, et al. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. PLoS Pathog. 2014;10:e1003890 pubmed 出版商
  336. Chang S, Kohrt H, Maecker H. Monitoring the immune competence of cancer patients to predict outcome. Cancer Immunol Immunother. 2014;63:713-9 pubmed 出版商
  337. Crawford T, Jalbert E, Ndhlovu L, Barbour J. Concomitant evaluation of PMA+ionomycin-induced kinase phosphorylation and cytokine production in T cell subsets by flow cytometry. Cytometry A. 2014;85:268-76 pubmed 出版商
  338. Narita T, Ishida T, Masaki A, Suzuki S, Ito A, Mori F, et al. HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation. J Immunol. 2014;192:940-7 pubmed 出版商
  339. Park S, Veerapu N, Shin E, Biancotto A, McCoy J, Capone S, et al. Subinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection. Nat Med. 2013;19:1638-42 pubmed 出版商
  340. Fuentes T, Appleby N, Tsay E, Martinez J, Bailey L, Hasaniya N, et al. Human neonatal cardiovascular progenitors: unlocking the secret to regenerative ability. PLoS ONE. 2013;8:e77464 pubmed 出版商
  341. Krishnan S, Wilson E, Sheikh V, Rupert A, Mendoza D, Yang J, et al. Evidence for innate immune system activation in HIV type 1-infected elite controllers. J Infect Dis. 2014;209:931-9 pubmed 出版商
  342. Tan A, Hoang L, Chin D, Rasmussen E, Lopatin U, Hart S, et al. Reduction of HBV replication prolongs the early immunological response to IFN? therapy. J Hepatol. 2014;60:54-61 pubmed 出版商
  343. Avanzi S, Leoni V, Rotola A, Alviano F, Solimando L, Lanzoni G, et al. Susceptibility of human placenta derived mesenchymal stromal/stem cells to human herpesviruses infection. PLoS ONE. 2013;8:e71412 pubmed 出版商
  344. Zuliani T, Saiagh S, Knol A, Esbelin J, Dreno B. Fetal fibroblasts and keratinocytes with immunosuppressive properties for allogeneic cell-based wound therapy. PLoS ONE. 2013;8:e70408 pubmed 出版商
  345. Nakayama K, Lee C, Batchelder C, Tarantal A. Tissue specificity of decellularized rhesus monkey kidney and lung scaffolds. PLoS ONE. 2013;8:e64134 pubmed 出版商
  346. Farley A, Morris L, Vroegindeweij E, Depreter M, Vaidya H, Stenhouse F, et al. Dynamics of thymus organogenesis and colonization in early human development. Development. 2013;140:2015-26 pubmed 出版商
  347. Bartholomeeusen K, Fujinaga K, Xiang Y, Peterlin B. Histone deacetylase inhibitors (HDACis) that release the positive transcription elongation factor b (P-TEFb) from its inhibitory complex also activate HIV transcription. J Biol Chem. 2013;288:14400-7 pubmed 出版商
  348. Gaur R, Suhosk M, Banaei N. In vitro immunomodulation of a whole blood IFN-? release assay enhances T cell responses in subjects with latent tuberculosis infection. PLoS ONE. 2012;7:e48027 pubmed 出版商
  349. Reuter M, Yuan S, Marx P, Kutzler M, Weiner D, Betts M. DNA-based HIV vaccines do not induce generalized activation in mucosal tissue T cells. Hum Vaccin Immunother. 2012;8:1648-53 pubmed 出版商
  350. Sölder E, Böckle B, Nguyen V, Fürhapter C, Obexer P, Erdel M, et al. Isolation and characterization of CD133+CD34+VEGFR-2+CD45- fetal endothelial cells from human term placenta. Microvasc Res. 2012;84:65-73 pubmed 出版商
  351. Landsverk O, Ottesen A, Berg Larsen A, Appel S, Bakke O. Differential regulation of MHC II and invariant chain expression during maturation of monocyte-derived dendritic cells. J Leukoc Biol. 2012;91:729-37 pubmed 出版商
  352. Ruffell B, Au A, Rugo H, Esserman L, Hwang E, Coussens L. Leukocyte composition of human breast cancer. Proc Natl Acad Sci U S A. 2012;109:2796-801 pubmed 出版商
  353. Fung E, Esposito L, Todd J, Wicker L. Multiplexed immunophenotyping of human antigen-presenting cells in whole blood by polychromatic flow cytometry. Nat Protoc. 2010;5:357-70 pubmed 出版商
  354. Souza Lemos C, de Campos S, Teva A, Corte Real S, Fonseca E, Porrozzi R, et al. Dynamics of immune granuloma formation in a Leishmania braziliensis-induced self-limiting cutaneous infection in the primate Macaca mulatta. J Pathol. 2008;216:375-86 pubmed 出版商
  355. Vodyanik M, Slukvin I. Directed differentiation of human embryonic stem cells to dendritic cells. Methods Mol Biol. 2007;407:275-93 pubmed 出版商
  356. Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood. 2007;110:1225-32 pubmed
  357. Contamin H, Loizon S, Bourreau E, Michel J, Garraud O, Mercereau Puijalon O, et al. Flow cytometry identification and characterization of mononuclear cell subsets in the neotropical primate Saimiri sciureus (squirrel monkey). J Immunol Methods. 2005;297:61-71 pubmed
  358. Yeaman G, Asin S, Weldon S, Demian D, Collins J, Gonzalez J, et al. Chemokine receptor expression in the human ectocervix: implications for infection by the human immunodeficiency virus-type I. Immunology. 2004;113:524-33 pubmed
  359. Boxall S, McCormick J, Beverley P, Strobel S, De Filippi P, Dawes R, et al. Abnormal cell surface antigen expression in individuals with variant CD45 splicing and histiocytosis. Pediatr Res. 2004;55:478-84 pubmed
  360. Braun R, Foerster M, Grahmann P, Haefner D, Workalemahu G, Kroegel C. Phenotypic and molecular characterization of CD103+ CD4+ T cells in bronchoalveolar lavage from patients with interstitial lung diseases. Cytometry B Clin Cytom. 2003;54:19-27 pubmed
  361. Hertel L, Lacaille V, Strobl H, Mellins E, Mocarski E. Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J Virol. 2003;77:7563-74 pubmed
  362. Higashi N, Morikawa A, Fujioka K, Fujita Y, Sano Y, Miyata Takeuchi M, et al. Human macrophage lectin specific for galactose/N-acetylgalactosamine is a marker for cells at an intermediate stage in their differentiation from monocytes into macrophages. Int Immunol. 2002;14:545-54 pubmed
  363. Belge K, Dayyani F, Horelt A, Siedlar M, Frankenberger M, Frankenberger B, et al. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol. 2002;168:3536-42 pubmed
  364. Gopinath R, Hanna L, Kumaraswami V, Perumal V, Kavitha V, Vijayasekaran V, et al. Perturbations in eosinophil homeostasis following treatment of lymphatic filariasis. Infect Immun. 2000;68:93-9 pubmed
  365. Basch R, Zhang X, Dolzhanskiy A, Karpatkin S. Expression of CD41 and c-mpl does not indicate commitment to the megakaryocyte lineage during haemopoietic development. Br J Haematol. 1999;105:1044-54 pubmed
  366. Lee B, Sharron M, Montaner L, Weissman D, Doms R. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc Natl Acad Sci U S A. 1999;96:5215-20 pubmed